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                                               Abstract  
Obstructive Sleep Apnoea Syndrome (OSAS) is the most common form of sleep 
disordered breathing characterised by snoring, apnoeic episodes, sleep 
fragmentation at night and excessive daytime sleepiness. Some patients with OSAS 
are at increased risk of being involved in road traffic accidents (RTA). Compared to 
other individuals, some OSAS patients are at 2-6 times at risk of having a RTA. 
Clinicians are not only involved in screening, diagnosing, managing patients with 
OSAS but are often asked to make recommendations about fitness to drive and this 
is likely to be inconsistent in the absence of objective criteria. Some clinicians advise 
against driving in high-risk patients and in certain situations inform the licensing 
authorities. Driving simulators have been used in the research setting to predict 
fitness to drive in various situations. Many studies have used simple simulators that 
were unrealistic. The Institute for Transport Studies at the University of Leeds has 
developed a sophisticated driving simulator (UoLDS). Alongside this, a PC-based 
simulator (Mini University of Leeds Driving Simulator, MUoLDS) has been developed 
using the same software. Using continuously measured variables it has been 
possible to identify, with a high degree of accuracy, a subset of patients with OSAS 
who fail a simulated driving test. This has the potential to identify at-risk drivers and 
improve the reliability of a clinician’s decision-making. Before the MUoLDS can 
become useful as a clinical tool there are a number of further questions to be 
answered and the thesis will address some of these.  
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Obstructive Sleep Apnoea Syndrome (OSAS) is the most common form of sleep 
disordered breathing characterised by snoring, apnoeic episodes during sleep and 
day time excessive sleepiness. It is a prevalent condition affecting up to 20% of the 
population in first world countries [1] and has a major impact on general health and 
functional status [2]. It can seriously affect the quality of life of the patient and their 
immediate family [3]. Previously considered to be a medical curiosity, snoring; more 
a subject of humour than one of serious investigation, has witnessed a paradigm 
shift and is being increasingly being recognized as a major health problem. Despite 
increased awareness, a majority of those affected are still undiagnosed [4]. 
According to a recent survey, 50-60% of the general public have heard of OSAS [5] 
and up to 80% of people with OSA have not been diagnosed [6]. The syndrome was 
first described in the latter half of the 19th century by Sir William Osler where he 
described obese persons suffering from extreme daytime sleepiness and coined the 
term “Pickwickian syndrome” inspired after a character in Charles Dickens, The 
Pickwick Papers [7]. After the introduction of sleep studies, new pathophysiological 
mechanisms were identified; one of these mechanisms was mechanical obstruction 
of the upper airways during inspiration and the term “obstructive sleep apnoea 
syndrome” was introduced [8]. The landmark discovery of Continuous Positive 
Airway Pressure (CPAP) treatment [9] revolutionised the clinical management of 
OSAS. Over the last few decades there have been countless studies looking into 
various aspects of OSAS that has led to better understanding of this chronic 
condition. 
 
1.1- Definition of OSA and OSAS 
OSA is characterized by repetitive episodes of partial or complete upper airway 
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obstruction occurring during sleep with brief cessation of air flow but continuing 
thoraco-abdominal movements. A reduction in airflow and peak signal excursion by 
30% is termed a “hypopnoea” and complete cessation of airflow for at least 10 
seconds despite ongoing inspiratory efforts termed an “apnoea”. These episodes 
lead to inadequate alveolar ventilation, usually result in oxygen desaturation and in 
prolonged events, a gradual increase in PaCO2. The events are often terminated by 
arousals which may be described by patients or their partners as gasps, choking 
episodes or snorting but most go unrecognised. OSAS is defined as the combination 
symptoms and five or more documented obstructive breathing events per hour [10]. 
 
1.2- Pathophysiology of OSA 
A vicious cycle of events commences at the onset of sleep (figure-1). Neural 
activation of the upper airways and pharyngeal muscles is reduced leading to 
muscular inactivity and atony. Partial or complete obstruction of the airways ensues 
which leads to hypoxia and/or hypercapnia and this leads to arousal from sleep. This 
cycle repeats continuously over the course of night leading to fragmented and 
unrefreshing sleep. OSA presents with a multitude of symptoms including snoring, 
witnessed apneas, nocturnal sweating, choking episodes, dry mouth, nocturia, 
excessive sleepiness, tiredness, poor work performance. The presence of day time 
sleepiness leads to a number of other problems such as driving impairment, 
accidents at work, cognitive decline, personality changes, mood disturbances, 
reduced libido secondary to low testosterone levels, martial disharmony and reduced  
quality of life. 
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Figure 1-1, adapted from Neil and McEvoy, Medical Journal of Australia 1997 [11] showing the 
pathophysiology of OSA. 
 
A study evaluating clinical predictors for sleep apnoea showed that snoring (P- 
0.001, OR= 2.5), excessive day time sleepiness (P- 0.002, OR= 1.7), witnessed 
apnoeas (P- 0.001, OR= 2.9) and impotence (P- 0.001, OR= 3.5) were the significant 
factors predicting OSA [12]. OSAS is diagnosed when there are symptoms of 
excessive daytime sleepiness or cognitive impairment along with an abnormal sleep 
investigation (overnight oximetry or limited channel sleep study or 
polysomnography). A number of factors should be taken into consideration such as 
shift work, sleep insufficiency, psychiatric disorders, metabolic disorders and 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Sleep Onset 
            Arousal Reduced CNS reflex 
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nutritional deficiencies, which may be the true cause of the sleepiness rather than 
objective measures on sleep diagnostics. 
 
1.3- History of Road Safety 
The first motor vehicle fatality in the United Kingdom and possibly the world was 
reported after a 44 year old mother of two, Bridget Driscoll died after being struck by 
a vehicle. The coroner at the inquest stated “I trust this sort of nonsense will never  
happen again” [13]. Sadly, the coroner, medical practitioners and general public 
would be deeply and repeatedly disappointed. It was 1896 and motor vehicles were 
a curiosity. Drivers did not undergo any form of testing, be it medical fitness, driving 
ability or otherwise, and there were no licensing regulatory agencies [14]. According 
to the World Health Organization (WHO), Road traffic accidents (RTA) were one of 
the top ten causes of death and in 2015 leading to 1.25 million injuries worldwide 
[15]. In the United Kingdom, a total of 195,723 casualties of road traffic accidents 
were reported by the public to the police in 2012 [16] and of these 1754 were fatal. 
For every death on Europe’s roads there are an estimated four permanently 
disabling injuries such as damage to the brain or spinal cord, eight serious injuries 
and fifty minor injuries [17]. 2011- 2020 was proclaimed by a United Nations General 
Assembly resolution (64/255) as the “Decade of Action” for road safety with a main 
goal of reducing the road fatalities at various levels world-wide [18]. 
 
The time line in the history of road safety, Highway Code and the various milestones 
achieved [19] are shown in table 1.1. 
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                Table 1.1 showing the time line in the history of road safety and Highway Code 
Year                                                   Event 
1888 First recorded sale of a motor car (petrol driven Benz) 
1903 Driver licences were first introduced in Britain by the Motor Car Act, 1903, 
purely a means of identifying vehicles and their drivers 
1930 Regulations introduced covering endorsements and fitness declaration. 
The Road Traffic Act 1930 introduces licensing system for PSV 
1931 The Highway Code was launched and the first edition urged all road users to be 
careful and considerate towards others, putting safety first 
1932 Diagrams of road signs as a warning about the dangers of driving when 
affected by alcohol or fatigue were seen in the second edition 
1933 Stopping distances made their first appearance in the third edition, along with 
new sections giving hints on driving and cycling 
1934 Licenses for lorry drivers were introduced on under the Road Traffic Act 
1935 Compulsory driver testing introduced 
1937 Speedometers and safety glass in windscreens made compulsory 
1950s The arrival of motorways led to the inclusion of a new section on motorway 
driving in the fifth edition of the Highway Code, advising drivers to avoid 
drowsiness by stretching their legs at the parking or service areas 
1965 DVLA set up 
1973 Centralised computer based licensing system was brought in to cope with the 
huge increase in demand for both driver and vehicle licences 
1990s Introduction of theory test 
2002 Hazard perception element was introduced in the theory test 
2011 Highway Code joined social networking websites Twitter and Facebook to share 
reminders of the road rules 
2012 The Official Highway Code app for smart phones was launched 
2017 Car driving test included following directions form a sat nav 
 
1.4- The relationship between OSAS and driving 
RTA can be caused by human error, environmental issues such as bad weather, 
poor road maintenance or issues with the vehicle. Up to one fifth (20%) of accidents 
on the UK motorways and other monotonous types of roads may be caused by driver 
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fatigue and sleepiness [20]. The morbidity and mortality associated with a sleep 
related RTA is high due to greater speed on impact and poor reaction to an 
impending event [20, 21]. RTAs related to sleepiness are common if driving alone or 
for a long distance without a break, in shift workers and those with untreated sleep 
disorders [21]. Sleep related RTA can also occur during the time of circadian rhythm 
change when vigilance is low (afternoon and nights), driving under the influence of 
alcohol or medications sleep deprivation and in shift workers [22]. Two thirds of 
drivers who fall asleep at the wheel are car drivers, 85% of the drivers causing sleep 
related RTA are men, and over one third are under 30 years of age [23]. 300 deaths 
in UK are caused by drivers falling asleep at the wheel every year [24]. RTA’s are 
extremely expensive to society, with fatal accidents costing over £1 million [25]. Poor 
sleep hygiene is the commonest cause of excessive daytime sleepiness (EDS) and 
untreated OSAS is the most common medical condition causing EDS [26]. One of 
the common causes for sleep related RTA is OSAS. It is well known that some OSA 
patients are at increased risk of being involved in a RTA and many population and 
various case control studies have reported this issue previously (Table 1-2). 
However many studies had relatively unmatched controls and were based on self- 
reported accidents rather than an objective record from police or licensing 
authorities. The other limitations in these studies were that there was a lack of robust 
questionnaire data, issue about recall bias, gender bias, underreporting of RTA’s and 
no data on the severity of sleep disordered breathing. 
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                               Table 1-2 showing the risk of RTA in OSA 
 
Author        Type of study Risk of RTA in OSA  
Findley et al (1988) [27] Case control (n = 29/35)           OR-7.0 
Haraldsson et al (1990) [28] Case control (n = 140/142)           OR-12.0 
Young et al (1997) [29] General population (n = 913)           OR-3.4 
George et al (1999) [30] Case control (n = 460/581)           OR-2.0 
Teran Santos et al (1999) [31] Case control (n = 102/152) OR-6.3 if AHI > 10/hour 
Horstmann et al (2000) [32] Case control (n = 156/160)          OR-12.0  
Mulgrew et al (2008) [33] Case control (n = 783/783) Severe OSA- RR 2.0  
 
A recent systemic review and meta-analysis by Garbarino et al [34] has shown that 
compared to controls, the odds of an accident at work was found to be nearly double 
in workers with OSA (OR = 2.18; 95% CI = 1.53 to 3.10). A meta-analysis comparing 
the risks for RTA in all medical conditions reported showed that OSAS has an 
increased risk between 1.2- and 2-fold with respect to a healthy population. It has the 
highest increased risk, with a relative risk of 3.71, which is second only to age and 
sex as a general risk factor for RTA [35]. Sleepiness is the greatest risk factor for 
RTA [36] and the risk of having a crash with untreated moderate to severe OSAS is 
superseded only by age and time of the day as risk factors [37]. Studies have shown 
that patients are reluctant to report accidents and under report symptoms [38, 39]. 
Data from police, relevant licensing authorities and insurers tend to underestimate 
the issue as not all incidents are reported, particularly near misses of nodding 
episodes that have not resulted in an accident. 
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Driving a vehicle is a skill that requires a combination of multiple factors. It involves 
complex integrated higher cortical function, alertness, concentration and eye to hand 
coordination [40]. A lapse in either of these may lead to increased RTA as evidenced 
by the study by McEvoy et al [41] who reported that driver’s using a mobile phone up 
to 10 minutes prior to a crash have a four fold increase in the likelihood of crashing. 
Sagaspe et al [42] undertook telephone interviews with French drivers and found that 
11.8% had an ESS =/> 11; 28.6% reported sleepiness at the wheel severe enough 
to require stopping, 46.8% felt sleepy during night-time driving and 39.4% during day 
time driving, 10% had had a near-miss during the previous year and 6% had had a 
driving accident. OSA is associated with focal loss of grey matter which may have an 
impact on an individual’s driving abilities [43]. Tippin et al [44] reported that drivers 
with OSA have reduced visual vigilance for peripheral targets and is postulated that 
this effect is due to decline in attention and fatigue. However it is not entirely clear 
what aspects of OSA increase the likelihood for poor driving ability. Potential 
confounders such as obesity and alcohol that may influence mechanical aspects of 
driver ability, reduced reaction times and poor evasive action respectively further 
complicate this. A recent study has shown that the rate of sleepiness and sleep-
related accidents among commercial drivers is high [45] and Howard et al [46] 
showed that 60% of drivers had sleep disordered breathing and 24% were 
excessively sleepy. Commercial drivers are considered as high risk because they 
operate larger vehicles, transport hazardous materials, carry multiple passengers, 
operate for long stretches of time and have an economic incentive to continue driving 
when non-commercial drivers may choose to stop. Multiple risk factors may 
synergistically increase the risk of accidents [47].  
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1.4.1- Position statements about OSAS and driving by various medical 
societies  
In population terms undiagnosed and untreated OSAS, irrespective of the severity is 
not compatible with safe driving and poses a serious public health concern with 
respect to road safety. The increased risk of RTA has prompted a specific 
consideration of OSA in the framework of the legislation for driving licenses. Rules 
for medical assessment before obtaining a driving licence differ from country to 
country. Position statements in recent years by various medical bodies [48,49] and 
licencing authorities [50] have attempted to tackle this issue. The American Thoracic 
Society (ATS) clinical practise guideline on Sleep Apnoea, sleepiness and driving 
risk in non-commercial drivers considers patients to be high-risk drivers if there is 
moderate-to-severe sleepiness plus previous RTA’s [49]. Annexe iii of the European 
Union (EU) directive on driving licences was revised in 2014 on the 
recommendations from a working group established by the transport and mobility 
directorate of the European commission in 2012 [51]. The new directive, which is 
subject to mandatory implementation by all member states from December 2015 
states that ‘Applicants or drivers in whom a moderate or severe obstructive sleep 
apnea syndrome is suspected shall be referred to further authorised medical advice 
before a driving licence is issued or renewed [51]. They may be advised not to drive 
until confirmation of the diagnosis. Driving licences may be issued to applicants or 
drivers with moderate or severe OSAS who show adequate control of their condition 
and compliance with appropriate treatment and improvement of sleepiness, if any, 
confirmed by authorised medical opinion. Applicants or drivers with moderate or 
severe obstructive sleep apnea syndrome under treatment shall be subject to a 
periodic medical review, at intervals not exceeding 3 years for drivers of group 1 (i.e. 
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non-commercial drivers) and 1 year for drivers of group 2 (i.e. commercial drivers), 
with a view to establish the level of compliance with the treatment, the need for 
continuing the treatment and continued good vigilance [51]. The European 
Respiratory Society has established a task force in the area of driving and OSA to 
develop guidance and help ensure that any adoption of EU 2014/85/EU is 
undertaken in a reasoned, sustainable and fair manner in line with each country’s 
legislative procedures and economic resources [52, 53]. 
 
1.4.2- OSAS and Driving Vehicle Licensing Authority (DVLA) - The current state 
of affairs 
Currently in the UK, the Driving Vehicle Licensing Authority (DVLA) [50] has specific 
guidelines that are applicable to all drivers who have OSAS. The current 
interpretation of the EU directive by the DVLA has caused some consternation 
among patients, sleep apnoea support groups and the clinicians (personal 
communications). The DVLA has focussed on both sleepiness sufficient to impair 
driving along with severity of sleep apnoea based on Apnoea- Hypopnea Index 
(AHI).  Based on the current guidelines the relevant patients by law should inform 
DVLA and complete the relevant form (SL1 for class one and SLV1 for class two 
licences) after a diagnosis has been confirmed. Once DVLA is informed, medical 
enquiries are undertaken to establish whether the driver should retain their licence. 
Driving will normally be allowed to continue once satisfactory control of the condition 
is achieved with CPAP, the gold standard in the management of OSAS. 
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                   Figure 1-2 adapted from DVLA [50] showing the current DVLA guidelines  
Randomised controlled trials have shown that CPAP improves subjective and 
objective sleepiness [54-56]. Adequate control of the underlying symptoms and sleep 
disordered breathing is essential before driving can be recommenced. This should 
be confirmed by the clinician, as there may be insurance implications in the event of 
a crash if unfit drivers drive against medical advice. Not reporting to the DVLA about 
a diagnosis of OSAS could result in a £1,000 fine. 99% of those with OSAS keep 
their licence [22]. By law, it is the patient’s responsibility not to drive if sleepy and the 
DVLA remains the final arbiter.  
 
1.5- Assessment of fitness to drive in OSAS patients 
Driving is an essential part of modern life and most patients with OSAS drive motor 
vehicles. A survey in 2013 by the British Lung Foundation (BLF) showed that among 
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a cohort of OSAS patients (n= 2671) attending sleep clinics in the UK, 82% of 
responders held a current driving licence, 62% drove a motor vehicle and 16% held 
a professional driving licence or drove for a living [57]. Some clinicians are not only 
involved in screening and treating OSAS patients but are often asked to make 
recommendations about fitness to drive which can be challenging with major 
implications on patients livelihood, in particular professional drivers. There is 
evidence that the risk of accidents increases with increasing daytime sleepiness [58]. 
Although there is a trend towards increased likelihood of accidents with more severe 
sleep disordered breathing there is no sufficient robust data on which to base 
decisions for an individual [59]. There is a duty of care on clinicians to discourage 
those patients who are at high risk of causing an accident from driving or even to 
report them to the licensing authorities. OSAS patients have a moral obligation ( a 
duty which one owes, and which he or she ought to perform, but which he or she is 
not legally bound to fulfil) to obey the law but due to the fear of losing their driving 
licence or livelihood may under report sleepiness at the wheel. A meta-analysis 
showed that making patients take the issue of potential unsafe driving seriously; 
using threat appeal generates fear and does not translate into positive change 
resulting in less risky driving behaviour [60]. DVLA remains the final arbiter and has 
the right to know about one’s driving fitness [50]. The advice that a patient will 
receive about driving will depend upon their doctor’s attitude to risk and this is likely 
to be inconsistent between clinicians in the absence of objective criteria. Clinician’s 
warnings to patients who are potentially unfit to drive may contribute to a decrease in 
subsequent RTA, but may also exacerbate mood disorders and compromise the 
doctor-patient relationship [61]. It may also dissuade others from seeking treatment 
for their own symptoms. General Medical Council (GMC) has published guidance 
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about breaching patient confidentiality in certain extreme circumstances in the 
interest of public safety [62].  Currently advice about an individual’s fitness to drive is 
based upon the severity of the sleep disordered breathing, with or without some 
objective measure of daytime sleepiness and the patient’s account of their driving 
[63, 64]. There are conflicting data about the relationship between perceived 
sleepiness and the likelihood of being involved in an accident. There is a problem 
inherent in the ascertainment of risk in an individual patient upon initial presentation. 
 
1.5.1- Assessment of sleepiness in OSAS patients 
A- Subjective sleepiness 
Using validated questionnaire such as the Epworth Sleepiness Score (ESS) and the 
Stanford Sleepiness Score (SSS), a subjective assessment is carried out. ESS is a 
well-validated tool to assess subjective sleepiness in OSAS. It is easy to administer 
and is useful in measuring changes in sleepiness over time. It is intended to 
measure daytime sleepiness on a probability scale of 0 to 3 in eight different 
situations during the day [65]. It was introduced in 1991 by Dr. Murray Johns of 
Epworth Hospital in Melbourne, Australia [65].  It has a total score of 24 and a score 
of less than 10 is considered as normal. A score of more than 10 is considered as 
abnormal and warrants further assessment. It is simple and easy to complete. 
However the disadvantages are that since it is subjective, patients may underplay 
their responses leading to bias. SSS utilizes a 7-point scale (1- fully alert, 7- 
struggling to stay awake) and the immediate state of sleepiness is assessed. 
However there is no relation to the severity of OSAS and is used only in prior to 
MSLT [2]. Guaita et al [66] recently developed the Barcelona Sleepiness Index which 
is a brief questionnaire of just two items, which correlates well with objective 
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sleepiness measures, oxyhemoglobin desaturation and is sensitive to change with 
therapy. This instrument could be helpful in the evaluation of sleepiness, both during 
routine clinical interviews as well as a screening method in epidemiological studies. 
Masa et al [67] suggested that enquiring about sleepiness specifically while driving 
may better predict accident risk rather than sleepiness in general.  
 
B- Objective tests of sleepiness 
Daytime sleepiness is influenced by an individual characteristics, sleep needs, 
psychologic condition, physical and mental activity. Objective tests for assessment of 
driving abilities are limited. No test is considered as a gold standard to assess 
excessive daytime sleepiness, which is considered as the most disabling symptom in 
OSAS.  Multiple Sleep Latency Test (MSLT) [68], Maintenance of Wakefulness Test 
(MWT) [69] and Oxford sleep resistance (OSLER) test [70] are useful clinical tests 
for the evaluation of excessive sleepiness but with limitations. The MSLT assesses 
an individual’s ability to fall asleep during the day and is not appropriate to assess a 
patient’s fitness to drive [71]. Young et al [29] found no difference in MSLT test 
scores between subjects involved in a RTA and those who were not. The MWT is a 
validated, objective measure of the ability of an individual to stay awake. However its 
relevance to driving in which an individual has to interact with their environment is 
questionable. The same is true of the OSLER, a behavioural equivalent of the MWT 
[70]. Evidence suggests a relationship between driving ability and the MWT in 
patients with untreated obstructive sleep apnoea [72, 73]. A pathological MWT is 
associated with simulated driving impairment; sleepy patients had more 
inappropriate line crossings than control drivers (p < 0.05) [72].  In a small study 
comparing patients with untreated OSAS and controls, Philip et al [73] showed that 
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the number of inappropriate line crossings correlated with MWT scores (r2= -0.339; 
P= < 0.05) but its suitability to evaluate real world performances and/or risks has 
been questioned [74].  
 
1.6- OSAS and driving simulator performance 
Undertaking studies during real time driving is not feasible and is unethical. 
Evaluating many aspects of safe driving is the key and driving simulators have been 
used in the research setting to predict fitness to drive in various situations and 
understand the driving behaviour under safe conditions. This is an alternative 
approach to identify those patients who are at high risk of having a RTA and there is 
evidence to show a good correlation between simulator performance and real time 
driving experience [75]. Various studies have been performed reporting the driving 
simulator performance in OSAS and controls. Findley et al [76] using a personal 
computer program simulating a monotonous highway drive showed that OSAS 
patients when compared to controls perform worse on the driving simulation lasting 
for 30 minutes. OSAS patients had significantly higher events as compared to 
controls (44 +/- 52 versus 9 +/- 7, P= < 0.05). George et al [77] developed a 
laboratory based divided attention driving test and studied the ability to detect 
impaired performance in sober controls, controls under the influence of alcohol 
(mean blood alcohol level, 95+/-25 mg/dl) and male OSAS patients. The simulator 
performance was worse in OSAS patient than controls in all measures, with the 
largest difference noted in tracking error. Half of the patients were worse than any 
control subject, with some showing performance worse than control subjects 
impaired by alcohol. Barbe et al [78] using the Steer-Clear computer program 
investigated the association between OSAS, RTA and simulator performance. OSAS 
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patients reported more real life accidents than controls (OR= 2.3; 95% CI: 0.97 to 
5.33) and were more likely to have had more than one accident (OR= 5.2; 95% CI: 
1.07 to 25.29, P= < 0.05). They had a lower level of vigilance and poorer driving 
performance (P= < 0.01). However there was no correlation between the degree of 
daytime sleepiness, the severity of SDB, level of vigilance, simulator performance 
and the risk of automobile accidents. Risser et al [79] in a case control study using a 
computer based driving simulator recorded lane position variability, speed variability, 
steering rate variability, and crash frequency. The frequency and duration of EEG-
defined attention lapses were also measured. They showed that OSAS patients as 
compared to controls demonstrated greater variability in speed, lane position, 
steering rate and had more crashes. EEG-defined attention lapses of longer 
duration, which increased with time, were noted in OSAS patients. Measures of lane 
position variability and crash frequency had a significant positive correlation with 
attention lapse frequency and duration. The poor performance appeared related to 
the EEG-defined attention lapses. Lane position variability appeared to be the most 
sensitive measure for assessing and quantifying impairment. This study showed that 
poorer driving performance and crashes are not entirely due to excessive 
sleepiness, but inattention due to sleepiness. Juniper et al [80] developed a steering 
simulator with a realistic view of the road ahead that allowed separate assessment of 
the two visual tasks required for steering a car, immediate positioning on road with 
reference to the road edges, and assessment of the curve of the oncoming road 
which allows faster driving. This was a case control study and both the groups 
performed three 30-min drives with the entire oncoming road or only the near part of 
the road or only the distant part of the road visible. OSAS patients performed 
significantly worse on the three different drives as measured by steering error (P= 
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<0.001), time to detect the target number (P = <0.03), and off road events (P = 
<0.03). Turkington et al [81] have shown that age, female sex and alcohol were the 
greatest determinants of a task failure on the divided attention steering simulator 
(DASS). A self-reported near miss was independently associated with a poor 
performance. The number of off-road events on the simulator was independently 
associated with a history of previous RTA (OR= 1.004, 95% CI 1.0004 to 1.008, P= 
<0.03). The ESS was independently associated with episodes of falling asleep at the 
wheel (OR= 1.21, 95% CI 1.12 to 1.31, P= <0.0001). They concluded that there was 
an independent relationship between driving ability in OSAS patients and 
performance on a simple computer based simulator. Pichel et al [82] in a study 
involving 129 OSAS patients and using both a steer clear simulator and the DASS 
showed that alcohol and SF-36, a measure of self-reported health status were 
associated with poor simulator outcome. Philip et al [73] showed that the driving 
outcome in OSAS patients with a 90-minute real life driving session correlated with 
MWT and ESS. The AusEd driving simulator has been validated and shown to be 
sensitive to fatigue in a range of experimental settings [83]. A recent study using the 
MUoLDS [84] has shown that variables recorded during approximately fifty minutes 
of simulated motorway driving on the MUoLDS can predict with reasonable accuracy 
the patients with OSAS who will be involved in a crash in the simulated scenario.  
Three groups of patients can be identified; those who crash when they really should 
not, those who do not crash at all and an intermediate group who crash in a situation 
in which even a reasonably alert driver might crash. In this study 72 patients were 
included in the exploratory phase of the study and 133 patients in the validation 
phase. Prediction models could predict “fails” with a sensitivity of 82% and specificity 
of 96%. The models were subsequently confirmed in the validation phase. These 
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were based on the SDLP and the reaction time to an event. Fully immersive 
simulators may be considered as a surrogate for real time driving, but are not cost 
effective and most importantly not easily available. 
 
1.7- Effect of CPAP treatment on driving simulator performance in OSAS 
patients 
Various studies have shown that CPAP can improve driving simulator performance 
in OSAS patients. The studies are shown in Table 1-3. 
            Table 1-3 showing the effect of CPAP treatment on driving simulator performance 
 
 
Vakulin et al [83] 
 
Driving simulator performance improved after  3 months of 
CPAP treatment with high adherence in patients with severe 
OSA but performance remained impaired compared to 
control subjects 
Findley et al [85] CPAP treatment improved driving simulator performance. 
Cassel et al [86] 
 
Accident rate significantly reduced on an 80 minute vigilance 
test with 12 months CPAP treatment. 
Hack et al [87] Improvement in simulator performance after 1 month of 
CPAP treatment. 
Turkington et al [88] Improvement in simulator performance after 7 days of CPAP 
treatment. 
Orth et al [89] 
 
Improve simulator performance with reduced accident rates 
after CPAP treatment. 
Mazza et al [90] CPAP treatment reduced the reaction time on simulator 
performance 
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1.8- Effect of CPAP treatment on real life road traffic accidents in OSAS 
patients 
There is also evidence that treatment with CPAP reduces real life RTA. Krieger et al 
[90] showed reduction in RTA and near miss events after CPAP. Yamamoto et al 
[92] reported that 33% of OSAS patients had accident/near miss before treatment 
and no mishaps after CPAP. In a study by George et al [93] comparing motor vehicle 
crash records between OSAS patients treated with CPAP and controls, increased 
accident events were noted in untreated OSAS patients prior to CPAP; post CPAP 
the number of accident events was similar to the control group. Barbe et al [94] 
showed that after 2 years of CPAP treatment the RR for RTA reduced from 2.57 to 
0.41. A meta-analysis that reviewed various observational studies that reported 
accident risk with OSA before and after treatment with CPAP found a significant 
reduction in risk following CPAP treatment [95]. Studies discussed so far have 
consistently shown that OSAS patients perform worse on any driving simulator and 
studies have also reported improvement in simulator performance and reduction in 
real time RTA in OSAS patients following CPAP treatment.  
 
1.9- My research  
My work focussed on the following aspects: 
I. To evaluate the degree of variability in clinician’s opinions regarding 
fitness to drive in patients with OSAS. 
This study focused on the current practice of advice given by clinicians 
regarding fitness to drive in patients with OSAS. This is discussed in Chapter-
3. 
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II. To establish a normal range based on self- report measures of 
sleepiness, sleepiness specifically whilst driving, safety-critical driving 
incidents based on a driving questionnaire, Mini University of Leeds 
Driving Simulator (MUoLDS) outcome and performance based on 
continuously measured variables in untreated OSAS patients and 
controls.  
            The aims of this exploratory cohort study were to define a normal range in 
            controls and to compare them with a group of untreated OSAS patients in 
            the following domains:  
 Self- reported sleepiness while driving 
 Safety – critical driving incidents  
 MUoLDS simulator performance  
in order to establish objective criteria to help inform the decision making 
process about an individual’s driving risk and investigate the role of an 
advanced PC based driving simulator as an objective tool for assessment. 
This is discussed in Chapter-4. 
 
III. Evaluate the issue of repeatability and the effect of an incentive on 
performance on the MUoLDS in untreated OSAS patients. 
This was a randomised trial which evaluated as a primary outcome the test-
retest reliability (repeatability) and the effect of motivation (incentive effect)   
on continuously measured driving parameters.  
a. Primary Outcome 
     Standard Deviation of Lane Position (SDLP) in epoch 3 and “veer”  
      reaction times (Veer-RT) were the primary outcome variables. 
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b. Secondary Outcome 
                      "Fail" or "Pass" during the simulated “drive”.  
         This is discussed in Chapter-5. 
 
IV. To explore the use of fatigue related counter measures (coping 
strategies) as a potential surrogate marker of sleepiness while driving in 
untreated OSAS patients and controls. 
This was an observational study that identified various behaviours adopted by 
controls and untreated OSAS patients to counter fatigue and sleepiness whilst 
driving. This study identified surrogate markers of fatigue and sleepiness. This 
is discussed in Chapter-6. 
 
V. To study cognitive dysfunction using the cognitive failure questionnaire 
and it’s impact on road traffic accidents in untreated OSAS patients and 
controls.  
This study tested the hypothesis that patients with OSAS exhibit worse 
cognitive dysfunction as compared to OSA patients and controls and higher 
CFQ score predicts accident risk. This study was divided into exploratory and 
validation phases. The outcomes were to explore the relationship between 
CFQ score versus general sleepiness, severity of sleep disordered breathing, 
accidents and to compare driving incidents between controls and patients. 
This is discussed in Chapter-7. 
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                                    Chapter 2  
  
Mini University of Leeds Driving Simulator (MUoLDS) 
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2.1- University of Leeds Driving Simulator (UoLDS) 
The Institute of Transport Studies in the University of Leeds consists of a 
multidisciplinary research team from engineering, psychology and computing back 
ground who have a research interest in traffic safety and human factors, road design, 
driver distraction and driver impairment. The previous UoLDS consisted of a 1991 
Rover 216GTi. Through government funding the existing space was refurbished and 
through competitive tender and negotiated budget of £911,952 the new UoLDS was 
developed between 2003- 2006. The cost covered motion system, vehicle cab, 
dome, projection, software and building. The design included real time controls, 
vehicle dynamics, motion sensors, image generation, eye tracking and in-vehicle 
touch- screen display. 
 
The UoLDS is a fully dynamic driving simulator located within the Institute for 
Transport Studies. The full simulator has a Jaguar s-type vehicle located inside a 
dome which sits on a motion system that can move in 6 degrees of freedom and 
slide along an x-y table as shown in figure 2-1.  
 
    Figure 2-1 showing the University of Leeds Driving Simulator 
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A driver has a near 360 degree view inside the dome of a road layout and 
surrounding area. In addition to the visual scene the driver will feel the physical 
sensation of accelerating, braking and turning the car. Third party applications may 
be run alongside the simulator to allow for more detailed data collection. Examples 
include the tracking of head & eye movements and measuring heart beats per 
minute. 
 
2.2- Mini University of Leeds Driving Simulator (MUoLDS) 
In addition to the full simulator above, the same software was installed on a single 
computer with one monitor. A single computer can easily be deployed in most indoor 
environments provided there is mains power. This allows for a single experiment to 
be run from more than one site at different times. However all the simulator tests in 
this research were conducted in St. James’s University Hospital. The software 
program was installed in two computer desktop (Windows-7) thus allowing multiple 
participants to run the same experiment at the same time.  For the purposes of 
various studies in patients with OSAS the simulator was used on two computers 
inside a hospital and was termed as the Mini University of Leeds Driving Simulator 
(MUoLDS). This is shown in 2-2. 
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                                    Figure 2-2 showing a photograph of the MUoLDS  
2.3- Running the MUoLDS 
Before running the simulator a subject number and a run number was created. Each 
participant had a unique subject number and could do one of two runs: 
a. Run 1 involved driving along a motorway for four junctions. 
b. Run 2 involved driving along a motorway for seven junctions and encountering 
drone vehicles.  
Provided that the subject and run numbers are valid then the software will start with 
a similar screen to that shown in figure 2-3. 
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                                        Figure 2-3 showing the road layout (dash board view)    
Figure 2-4 shows a subject seated on the MUoLDS prior to the test.                   
        
                     Figure 2-4 showing a subject on the MUoLDS (subject consent obtained) 
 
28 
 
Once the simulation test has started then the participant can start the engine. Figure 
2-5 shows the steering wheel, gearbox and pedals for the Logitech G27 racing 
wheel. Although this setup can be used to simulate a manual gearbox the simulator 
for Sleep Apnoea uses an automatic gearbox. In the middle of the gearbox there are 
four red buttons. Pressing the red button on the right starts the engine. The rev 
counter will idle around 500 rpm. To engage the drive gear the red button that is 
second to the right should be pressed and the car will automatically move unless the 
brake is applied. 
 
   Figure 2-5 showing the logitech G27 racing wheel, gear box and foot pedals 
Once the drive gear is engaged there is no need to disengage. Equally there is no 
facility to turn off the engine. Once the participant has finished their drive, pressing 
the Esc key on the keyboard ends the simulation. 
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2.4- Post processing the results 
Post processing the results was done in two parts. The first part extracted all the 
required information from a binary file (as generated by the real-time software) and 
saves the results to different text files (one file for the subject car information and 
another file for each of the drone vehicles). The second part extracted relevant 
information from the text files, using MATLAB or Octave and generated summary 
results. The script for processing was provided by Michael Daly and Tony Horrobin 
from the Institute of Transport Studies, University of Leeds. I installed the software 
for the MUoLDS runs, processing and extracting the results. After the one raw 
dataset has been processed then there were three choices for processing more 
data. 
a. Process more data as above. 
b. Place multiple commands like the one above inside a batch file and process more 
than one dataset. 
c. Move on to processing the text files. 
2.5- Processing the text files 
After the raw binary files have been processed the resulting text files were generated 
and placed in a subdirectory called debug. A typical file for the participant vehicle is 
shown in figure 2-6. 
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                                Figure 2-6 showing the text summary file 
The debug directory contained one file for the participant vehicle per run and one file 
per drone vehicle per run. The drone files were used for the analysis of the wobble 
and hard braking events in run 2. Although files were created for each of the drone 
vehicles, in practice only the drone vehicles involved with the wobble and hard 
braking events were needed for analysis. Therefore these files needed to be copied 
elsewhere and the remainder were deleted.  
2.6- Transferring the data files 
To transfer the correct drone files, the octave icon was double clicked and the octave 
program launched. To transfer the relevant files out of debug, the following transfer 
command was followed: 
a. transfer (start subject, stop subject, run number) or: 
b. transfer (1,1,2) 
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In this case only one subject run was done because the first and second numbers 
were the same. Multiple subjects can be transferred by entering a range of subjects. 
For example to transfer subjects 1 to 101 for run 2: transfer (1,101,2).  
To process the text files the octave icon was double clicked in order to start a second 
copy of octave. To process data for a single run the command shown was entered. 
This command processed the data for subject 1 run 2. To process multiple runs, a 
separate command was entered. This processed subjects 1 to 101 for runs 1 and 2. 
It takes octave 2-3 hours to process 100 subjects.  
2.8- Generate a summary of the results 
Many results files were generated after all subject runs have been processed. One 
last step was to combine all the required results and save them into two summary 
files (sleep_all.dat and sleep_lanes.dat). This was done for an efficient analysis of 
the simulator runs. To generate the results a specific command was entered. The 
resulting files sleep_all.dat and sleep_lanes.dat were tab delimited and were 
exported to Microsoft excel.  
 
2.9- MUoLDS road layout 
In line with the UK highways agency road standards, a three-lane motorway was 
developed with UK standard lane markings and signage. The road is 90 km long and 
comprises of 8 junctions, including entry, hard shoulder and exit slip roads, 
separated by 8 sections of road (each 9km in length). The designed road starts from 
junction 35 to 42 on M1. It takes approximately 7 minutes to drive one section at 
70mph. This will be called as one epoch. The complete scenario comprises eight 
similar epochs.  
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2.10- MUoLDS scenario 
All OSAS patients and controls had the scenario explained and had a 20 minute 
practice run before commencing the test proper. All through the test, drone vehicles 
will drive in and out of the subjects’ lane and it is expected that drivers would react to 
them as they would in real life. In the test proper a “minor” or “veer” event was 
choreographed within epoch 4. This was a scenario whereby a vehicle swerves 
briefly into the driver’s lane just ahead of them. This requires an avoidance 
manoeuvre such as braking or swerving (or both), but the vehicle is sufficiently far 
ahead that it was anticipated that an alert, competent driver should easily be able to 
avoid a collision. A “major” or “brake” event was inserted into epoch 8 which 
signalled the end of the run. Here, a vehicle ahead brakes heavily, requiring the 
driver to be fully attentive and reactive in order to avoid a collision. However, even 
with full attention some subjects might not be able to avoid a crash. The scenario 
was coordinated such that all drivers would be at the same time to collision when the 
car ahead starts to brake; thus all drivers are faced with a comparable task.  
Previous simulator studies suggest that “minor” events may precede “major” events 
[88]. All subjects were instructed to drive in the middle lane and were asked not to 
change lanes to overtake the vehicle in front but to try to keep up with it. This was to 
generate comparable and consistent data. 
 
2.11- Measures and end points 
Task failure was initially defined as unprovoked crash, veer event crash, unable to 
complete the test or spending more than 5% of the total study time (2 ½ minutes) 
with two wheels out of the middle lane. Unprovoked task failure and crashes at the 
minor event should not happen during normal simulated driving and any subject 
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falling into this category was considered to have “failed” the simulator test. Subjects 
who completed the test without meeting any of the task failure criteria defined above 
were deemed to have “passed”. The major event was choreographed such that it 
was harder to avoid a crash and those who only crashed at this event were deemed 
to be “indeterminate”. 
Various continuous variable parameters of driving behaviour were recorded at 60 Hz. 
These included minimum time headway (Hw), percentage time spent with minimum 
headway of less than 1 second (Hw1s), minimum time to collision (TTC) to the 
preceding vehicle, high frequency steering (HFS), mean speed and speed variation, 
standard deviation of lane position (SDLP), lane changes. For the purpose of 
analysis we used the mean values for each parameter in epochs 3, 5, 6 and 7, which 
were free of events and just require steady driving at approximately 70 mph. In 
addition, specific measures at the programmed events were also recorded, including: 
speed on approach to collision and reaction times (RT). 
 
2.12- Definitions of various driving simulator parameters 
      2.12.1- Time to Collision (TTC) 
This is defined as the instantaneous time it would take to collide into the lead vehicle 
if vehicle speeds are kept constant. It is measured in seconds. TTC reflects risk 
margin; the lower the TTC, the less margin for error, the lower the value of TTC 
minima, higher the risk [96]. 
 
       2.12.2-Time Headway (Hw) 
 This defined as the time it would take to collide into the lead vehicle were it to stop 
dead. Time Headway is a measure of longitudinal risk margin. The closer and faster 
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a subject travels behind a lead vehicle, the less the chance of managing to avoid a 
collision if the lead vehicle reduces their speed. For a small headway, the time a 
subject can be distracted by another task without a highly increased risk of accident, 
is much less than if the time headway is large. The proportion of the time headway 
less than one second (Hw1s) has been used as a risk indicator for car following 
situations. A higher proportion of time spent with headway less than 1 second 
(Hw1s) is an indicator of worse performance and dangerous driving [97, 98]. 
Minimum time headway is the minimum value of headway reached in a particular 
epoch; a lower value indicates poorer driving performance. It is measured in 
seconds. 
 
      2.12.3- Standard Deviation of Lateral Position (SDLP)  
Less lateral control may be observed as an increase in SDLP. In several studies, 
driver sleepiness (drugs, sleep deprivation) has been shown to cause an increase in 
SDLP; the steering control has become less stable. However, SDLP is influenced by 
overtaking and voluntary changes in lateral position due to road curvature; effects 
that may not be related to driving performance. Hence in all the studies subjects 
were asked to stay in the middle lane all through the runs and we took into account 
the SDLP only from the straight sections of the road. Higher SDLP relates to worse 
vehicle control [80, 99]. It is measured in meters. 
 
      2.12.4- High frequency steering activity (HFS) 
The high frequency component of steering activity is measured as a ratio between 
steering movements of 3- 6 Hz to all other steering activity. Higher HFS indicates 
poorer control [100, 101]. 
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       2.12.5- Reaction time (RT) 
Time between the lead vehicle commencing veering or braking manoeuvre and 
participant commencing braking. If the patients failed to brake the reaction time was 
infinity and if they veered out of lane to avoid crash no RT was recorded. It is 
measured in seconds.  
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                                 Chapter-3 
 
Variability in clinicians’ opinion regarding fitness to 
drive in patients with OSAS 
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3.1- Abstract 
OSAS is an important risk factor for RTAs. Clinicians have to advise patients about 
driving but there are no clear standards or guidelines. The current practice of advice 
given by clinicians regarding fitness to drive in OSAS patients was evaluated. 
Clinicians were invited to complete a web-based survey, including vignettes of 
patients with OSAS at diagnosis and following treatment with CPAP. Clinicians were 
asked to indicate the advice they would give about driving and what they considered 
to be residual drowsiness and adequate compliance following treatment with CPAP.  
467 respondents (58% males) completed the survey. 53% were consultants who 
saw patients with OSAS. Conflicting advice was given by different clinicians for each 
vignette at diagnosis. In the least contentious, 94% of clinicians would allow driving; 
in the most contentious a patient had a 50% chance of being allowed to drive. 
Following treatment with CPAP clinicians’ interpretation of what constituted residual 
drowsiness was also conflicting.  In each vignette the same clinician was more likely 
to say “yes” to “excessive” than to “irresistible” (71+/12% v/s 42+/-10%, P-0.0045), 
consistent with a higher standard being applied to vocational drivers, as intended by 
the DVLA. There was also a lack of consensus regarding “adequate CPAP 
compliance”; “yes” responses ranged from 13% to 64%. Analysis of responses to an 
open question revealed that driving and sleep apnoea was a difficult issue for 
clinicians to manage (qualitative analysis). There is considerable variability in the 
advice likely to be given by clinicians about driving. It is an area that clinicians found 
difficult and in which they feel vulnerable. There is a desire for clearer guidance.  
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3.2- Introduction 
OSAS is prevalent in approximately 4% of men and 2% of women, and is 
characterised by sleep fragmentation and excessive daytime sleepiness [102-105]. 
Excessive daytime sleepiness decreases reaction times, vigilance and alertness, 
which affect certain tasks requiring sustained attention, such as driving. Sleepiness 
at the wheel is estimated to cause about 20% of motorway accidents, which usually 
occur at high speed without avoidance reactions [20, 30, 32]. OSAS patients are 2 to 
6 times more prone to RTAs when compared to other individuals [29, 78] and a 
meta-analysis has shown that OSAS carries the highest risk for RTAs amongst a 
variety of medical conditions [31, 35]. However not all OSAS patients are unsafe 
drivers [106]. Clinicians diagnosing OSAS will need to advise patients about driving. 
Furthermore they are often asked by the DVLA and employers to make 
recommendations about a patient’s fitness to drive. There is an obligation on 
clinicians to discourage those patients who are at high risk of causing an accident 
while driving or to report them to the DVLA. This survey was carried out to gauge the 
advice patients are likely to be given about driving by clinicians. 
 
3.3- Methods 
Clinicians who saw patients with OSAS were invited to participate in a web-based 
survey, conducted under the auspices of the British Thoracic Society (BTS) in 
collaboration with the British Sleep Society (BSS) and the Association for 
Respiratory Technology and Physiology (ARTP, UK). A link to the survey was sent 
out by email to all members of these societies. Recipients were asked to complete 
the survey only if they saw patients with OSAS and to forward the link to colleagues 
who might see patients with OSAS, but who were not members of the above 
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societies. We conceived and designed the survey and I supervised and analysed the 
survey results.  
 
3.4- Survey Questionnaire 
The survey was divided into two parts. The first was completed by all the 
respondents and included six vignettes. These presented a variety of patients with 
OSAS; for each the respondent chose from one of five recommendations regarding 
the patient’s driving ranging from no restriction to advising not to drive at all.  The 
second part was limited to clinicians who completed DVLA medical forms (SL2C and 
SL2VC). Respondents were presented with further vignettes of patients who had 
been offered CPAP, focusing on the questions posed by the DVLA. Additional 
information was requested, including on the use of objective tests for assessing 
fitness to drive. Three sleep specialists from the BTS Specialist Advisory Group 
reviewed the vignettes and confirmed that they were reflective of everyday clinical 
practice. Respondents were reminded twice to answer as if there was a real patient 
before them and not how they thought they would be expected to respond.  
 
3.5- Clinical Vignettes 
Each vignette described an OSAS patient who either had one or more of the 
following factors; normal or abnormal ESS; sleepiness specific whist driving such as 
episodes of nodding and/or driving on the rumble strip; moderate or severe sleep 
disordered breathing and any other significant factor contributing to their underlying 
clinical condition such as shift working pattern or BMI. Respondents were asked to 
choose one option from five of the advice they would give in a real time clinical 
situations for each of the vignettes. Part 2 presented further vignettes from patients 
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who had been treated with CPAP and focussed on questions asked by the DVLA. All 
the vignettes are described below. 
 
Part-1 Vignettes (To all the respondents) 
1- The patient had a sleep study because of loud snoring. No daytime sleepiness 
and in particular no problems driving. A sleep study has shown AHI 18 events per 
hour; the Epworth score is 7.  How would you advise the patient about driving?   
A- Can drive without restriction, but like anyone else should not drive if feel sleepy 
B- Can drive, but should avoid long journeys, motorway driving etc, until satisfactorily 
     treated 
C- Should not drive at all, until satisfactorily treated 
D- I would not offer the patient any advice about driving 
E- Others, please specify 
……………………………………………………………………………………………….. 
2- The Patient presented to their GP because of loud snoring and concern about 
occasional witnessed apnoeas. They deny daytime sleepiness and in particular say 
no problems driving; even long distances. A sleep study has shown AHI 45 events 
per hour; Epworth score 3.  How would you advise the patient about driving?   
A- Can drive without restriction, but like anyone else should not drive if feel sleepy 
B- Can drive, but should avoid long journeys, motorway driving etc, until satisfactorily 
     treated 
C- Should not drive at all, until satisfactorily treated 
D- I would not offer the patient any advice about driving 
E- Others, please specify 
………………………………………………………………………………………………….. 
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3- Patient consulted GP because of tiredness. GP elicited a history of snoring and 
questioned possibility of obstructive sleep apnoea. Sleep study:  AHI 25 events / 
hour; Epworth score 15. Says no problems at all with sleepiness while driving- 
recently drove 4 hours on a motorway without a break and with no problems. How 
would you advise the patient about driving?     
A- Can drive without restriction, but like anyone else should not drive if feel sleepy 
B- Can drive, but should avoid long journeys, motorway driving etc, until satisfactorily 
     treated 
C- Should not drive at all, until satisfactorily treated 
D- I would not offer the patient any advice about driving 
E- Others, please specify 
…………………………………………………………………………………………………. 
4- Patient referred by ENT to whom had presented with troublesome snoring. This 
was prompted by the partner; patient denies a problem.  Sleep study: AHI 17 events 
/ hour; Epworth 17. Shift worker (alternating 4 days 3 nights with breaks between). 
Patient only falls asleep if relaxing or bored. Never if occupied. Patient says that this 
is typical of most of work colleagues. Says that has never had any problems driving; 
apart from once year ago on a very long drive; 10 hours; returning from holiday; 
when nodded off very briefly. How would you advise the patient about driving?   
A- Can drive without restriction, but like anyone else should not drive if feel sleepy 
B- Can drive, but should avoid long journeys, motorway driving etc, until satisfactorily 
     treated 
C- Should not drive at all, until satisfactorily treated 
D- I would not offer the patient any advice about driving 
E- Others, please specify 
………………………………………………………………………………………………….. 
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5- A sleep study was performed as part of routine work up of a patient being 
assessed for bariatric surgery. The patient admits to being “a little sleepy 
occasionally” but had not thought much of it until now. They would not have bothered 
to see their GP about it. During motorway driving gets tired after 1 hour. Has nodded 
on one occasion a couple of years ago - since then says always stops for a rest as 
soon as starts to feel tired. Sleep study: AHI 30 events per hour; Epworth 18.  How 
would you advise the patient about driving?  
A- Can drive without restriction, but like anyone else should not drive if feel  
     sleepy 
B- Can drive, but should avoid long journeys, motorway driving etc, until 
     satisfactorily treated 
C- Should not drive at all, until satisfactorily treated 
D- I would not offer the patient any advice about driving 
E- Others, please specify 
…………………………………………………………………………………………………. 
6- AHI 55 events per hour; Epworth score 18. Patient denies any problems driving 
but then recounts a recent journey on a motorway during which describes nodding at 
the wheel and hitting the rumble strip on several occasions. Says it was a one off 
after an early start; a much longer drive than does normally and a particularly hard 
day’s work. Says does not normally drive on motorways; driving usually confined to 
maximum 20 minutes to and from work; to shops etc. How would you advise the 
patient about driving?   
A- Can drive without restriction, but like anyone else should not drive if feel sleepy 
B- Can drive, but should avoid long journeys, motorway driving etc, until satisfactorily 
     treated 
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C- Should not drive at all, until satisfactorily treated 
D- I would not offer the patient any advice about driving 
E- Others, please specify 
………………………………………………………………………………………………….. 
Part-2 Vignettes (Only for clinicians completing DVLA forms) 
 
The DVLA forms sometimes ask about “irresistible” and sometimes about 
“excessive” drowsiness and about whether the patient is adequately 
compliant with treatment. We would like you to answer these questions for 
each of the following patients. PLEASE ANSWER ALL QUESTIONS AS IF THIS 
WAS A REAL PATIENT - SAY WHAT YOU WOULD DO IN EVERYDAY CLINICAL 
PRACTICE.    
 
1- Patient with AHI 35/hr Epworth 22. Now established on CPAP. Recent AHI 10/hr 
on CPAP - machine used 7 hours that night. Epworth 14. Patient says feels much 
better and that he is no longer having problems driving.   He does still fall asleep 
watching television in the evening, but not at other times. A download from the 
machine reveals that he is using it for an average of 3.2 hours per night with a range 
of 0 to 7 hours.  He had stopped driving (his decision) but has now restarted.  
 
A- Is the patient adequately compliant with treatment-? 
Yes/ No 
B- Does the patient continue to experience irresistible drowsiness-? 
Yes/No 
C- Does the patient continue to experience excessive drowsiness-? 
Yes/No 
………………………………………………………………………………………………….. 
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2- At diagnosis - AHI 28 events per hour, Epworth 15. On CPAP AHI 3, Epworth 5. 
Average use 6 hours per night. Patient regularly spends weekends in a caravan, a 3 
hour drive away. Does not use CPAP in caravan because there is no electricity and 
admits to sometimes feeling drowsy at the wheel returning home on Sunday night. 
His partner does not drive.  
A- Is the patient adequately compliant with treatment-? 
Yes/ No 
B- Does the patient continue to experience irresistible drowsiness-? 
Yes/No 
C- Does the patient continue to experience excessive drowsiness-? 
Yes/No 
………………………………………………………………………………………………… 
3- Diagnostic AHI 45 events / hr, Epworth 14. Now established on CPAP AHI 7 
Epworth 9. Average use 4 hours per night, but wide range. Usually does not use at 
all two nights per week. The days following a night without CPAP admits to falling 
asleep during breaks at work, but says has no problems driving. 
A- Is the patient adequately compliant with treatment-? 
Yes/ No 
B- Does the patient continue to experience irresistible drowsiness-? 
Yes/No 
C- Does the patient continue to experience excessive drowsiness-? 
Yes/No 
…………………………………………………………………………………………………. 
4- Diagnostic AHI 80 events per hour, Epworth 22, patient admitted falling asleep 
regularly while driving. On CPAP AHI 10 events per hour Epworth 12. Says feels 
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much better and no longer having any problems driving but continues to fall asleep 
watching television, while reading and if a passenger in a car.    
A- Is the patient adequately compliant with treatment-? 
Yes/ No 
B- Does the patient continue to experience irresistible drowsiness-? 
Yes/No 
C- Does the patient continue to experience excessive drowsiness-? 
Yes/No 
………………………………………………………………………………………………….. 
5- Patient with AHI 35 events/hour, Epworth score 13. Prior to diagnosis the patient 
admits that continued to drive despite regularly nodding at the wheel, because “had 
to”. On a couple of occasions had found himself driving over the rumble strip onto 
the hard shoulder. Tried CPAP but could not tolerate it at all. Has decided to lose 
weight and has lost 3 kg so far over two months. Says feels better. Epworth score is 
12. There is a moderate chance of dozing or falling asleep watching TV, reading, 
sitting quietly after lunch, lying down for a rest in the afternoon and as a passenger in 
a car for an hour without a break. Says that has now realised the importance of not 
driving when tired and whenever starts to feel tired always stops for a rest and a cup 
of coffee. Says that since tried CPAP has never nodded while driving nor driven over 
the rumble strip.  
 
A- Is the patient adequately compliant with treatment-? 
Yes/ No 
B- Does the patient continue to experience irresistible drowsiness-? 
Yes/No 
C- Does the patient continue to experience excessive drowsiness-? 
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Yes/No 
…………………………………………………………………………………………………………………………………………………….  
3.6- Objectives 
   3.6.1- Primary Objective 
To assess the degree of variation in advice a patient with OSAS might receive in 
everyday clinical practice at diagnosis and after starting CPAP.  
 
   3.6.2- Secondary Objectives 
To establish which factors, if any, influenced the advice given, to evaluate the use of 
objective tests in assessing fitness to drive and whether clinicians report patients to 
the DVLA. 
 
3.7- Statistical analysis 
The statistical analysis was carried out using Graph Pad Prism 6 software, San 
Diego California USA and SPSS version 20. Statistical significance was set at p < 
0.05. Chi-square tests were used to evaluate which factors influenced the advice 
given. As the respondents were matched pairs of subjects, McNemar’s test was 
used to establish the significant difference in the residual drowsiness. Binary logistic 
regression analysis was performed to evaluate the significant variables. Data that 
were not normally distributed are presented as median and Inter quartile range. 
Qualitative analysis was done using thematic analysis [107]. 
 
3.8- Results 
Approximately 3150 members of the BTS, BSS and ARTP were invited to complete 
the survey. 467 (15%) respondents completed the first stage of the survey, 210 said 
they completed forms for the DVLA and of these 178 completed the second stage.  
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Although the response rate of 15% appears low it should be stressed that those who 
received the e-mail were told they should only complete the survey if they saw 
patients with OSAS and advised them about driving; for reference 538 BTS 
members indicate that sleep medicine is one of their 3 specialty interests. In the ERS 
there are 461 members affiliated to Group 04.02 (Sleep and Control of Breathing) as 
main group, among which 27 are from UK. I believe therefore that the survey results 
reflect the views of clinicians working in this field. 
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3.8.1- Demographics (Table 3-1) 
                                 Table 3-1 showing the demographical details of the respondents 
Professional background  
Sleep Consultant 109 (23%) 
Non Sleep Consultant 138 (30%) 
Specialist Trainee 103 (22%) 
General Practitioner 3 (1%) 
Nurse 44 (9%) 
Physiologist 48 (10%) 
Others 22 (5%) 
Gender  
Males 272 (58%) 
Females 195 (42%) 
OSAS patients seen per month  
None 21 (4%) 
1-5/month 167 (36%) 
6-20/month 119 (26%) 
> 20/month 160 (34%) 
Age of the respondents  
Less than 35 Years 115 (24%) 
36-50 Years 251 (54%) 
More than 50 Years 101 (22%) 
Region of Work  
Northern Ireland 6 (2%) 
Wales 17 (3%) 
East Of England 23 (5%) 
South East Coast 23 (5%) 
South Central 25(5%) 
North East 34 (7%) 
East Midlands 32 (7%) 
Scotland 31 (7%) 
West Midlands 36 (8%) 
South West 46 (10%) 
North West 50 (11%) 
London 63 (13%) 
Yorkshire and Humber 81 (17%) 
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  3.8.2- Advice given at diagnosis of OSAS 
There was wide variability in the advice given in all the six vignettes (Figure 3-1).  To 
a patient what matter is whether driving is permitted or not. For this reason, and for 
subsequent ease of presentation and analysis, responses “would not give advice” or 
“other” are omitted and data presented in table 3-2 as “yes” would allow driving [no 
restriction (option 1) and would allow driving but should avoid long journeys and 
motorways (option 2)] versus “no” should not drive at all (option 3). Respondents 
who chose “would not give advice” and “other” were specialist nurses and non-
medically qualified professionals including sleep physiologists. Conflicting advice was 
given by different clinicians for each vignette. In the least contentious (vignette-1) 
94% of clinicians would allow driving. In the most contentious (vignette-3) a patient 
had a 50% chance of being allowed to drive. 
 
Figure 3-1 showing the likelihood of conflicting advice given by the clinicians at diagnosis of OSAS.  
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Vignette-1 Vignette-2 Vignette-3 Vignette-4 Vignette-5 Vignette-6
Can Drive Cannot Drive
50 
 
      Table 3-2 showing the percentage of patients who would be advised they could and could not drive. Key information from each vignette is also presented.  
                                   
             
Vignette ESS Any sleepiness  while driving AHI Other Factors “Yes” (%) “No” (%) 
“Yes” (%) 
95% CI 
“No” (%) 
95% CI 
1 7 Nil 18/hr Nil 94% 6% 92%-96% 4%-8% 
2 3 Nil 45/hr Nil 71% 29% 61%-81% 19%-39% 
3 15 Nil 25/hr Nil 42% 58% 32%-52% 48%-68% 
4 17 Nodded briefly 17/hr Shift worker 50% 50% 40%-60% 40%-60% 
5 18 Nodded Once 30/hr 
Bariatric surgery 
assessment 
23% 77% 15%-31% 69%-85% 
6 18 Nodded, hit rumble strip 55/hr Nil 13% 87% 9%-17% 83%-91% 
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3.8.3- Reasons for variability in the advice given   
      3.8.3.1- Gender  
There was a statistically significant difference in the driving advice given in vignettes 
2 to 5 respectively depending on the gender of the respondent (Table 3-3). Female 
clinicians are more likely than male clinicians to advise patients to continue driving. 
                               Table 3-3 showing the gender variation in various clinical vignettes 
 
Vignette Females  
“Can Drive” 
Females 
“Cannot Drive” 
Males 
“Can Drive” 
Males 
“Cannot Drive” 
 
P- Value OR   (95% CI) 
1 161 (95%) 9 (5%) 233 (94%) 16 (6%) 0.63 1.22 (0.5-2.8) 
2 105 (66%) 55 (33%) 185 (75%) 62 (25%) 0.04 0.63 (0.4-0.9) 
3 84 (49%) 89 (51%) 89 (36%) 155 (64%) 0.01 1.64 (1.1-2.4) 
4 101 (59%) 73 (41%) 114 (45%) 139 (55%) 0.008 1.68 (1.1-2.4) 
5 50 (27%) 132 (73%) 50 (19%) 209 (81%) 0.04 1.58  (1.0-2.4) 
6 29 (16%) 155 (84%) 31 12%) 234 (88%) 0.21 1.41 (0.8-2.4) 
                     
      3.8.3.2- Professional background 
Consultants with a special interest in sleep medicine are more likely to advise 
patients to continue driving in vignettes 2, 5 and 6 respectively when compared to 
those without a special interest in sleep medicine (Table 3-4). However there was no 
difference in the advice given when the consultant grade was compared to non 
consultant grade (trainees, general practitioner and allied health care professionals) 
(Table 3-5). 
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Table 3-4 showing the difference in advice given in various clinical vignettes between sleep and non-
sleep consultants 
 
Table 3-5 showing the difference in advice given between consultants and other health care 
professionals in various clinical vignettes  
                                  
Vignette Consultant  
“Can Drive” 
Consultant 
“Cannot Drive” 
Non Consultant 
“Can Drive” 
Non Consultant 
“Cannot Drive” 
P- Value OR  (95%CI) 
1 210 (94%) 14 (6%) 156 (95%) 9 (5%) 0.74 0.86 (0.36-2.0) 
2 156 (72%) 60 (28%) 116 (71%) 47 (29%) 0.82 1.05 (0.67-1.6) 
3 82 (38%) 136 (62%) 61 (41%) 87 (59%) 0.48 0.85 (0.56-1.3) 
4 105 (48%) 115 (52%) 94 (55%) 77 (45%) 0.15 0.74 (0.5-1.1) 
5 50 (22%) 178 (78%) 42 (24%) 131 (76%) 0.57 0.87 (0.54-1.3) 
6 28 (12%) 206 (88%) 25 (14%) 150 (86%) 0.48 0.81 (0.45-1.4) 
 
3.8.3.3- Number of patients seen  
The advice given to OSAS patients was dependent on the number of patients seen 
per month by the clinician. Respondents who saw more than 5 patients per month 
were more likely to advise patients to continue driving compared to those who saw 
less than 5 patients per month. This was statistically significant in vignette 2 and 6 
respectively (Table 3-6). 
 
 
 
Vignette Sleep Consultant 
“Can Drive” 
Sleep Consultant 
“Cannot Drive” 
Non Sleep 
Consultant 
“Can Drive” 
Non Sleep 
Consultant 
“Cannot Drive” 
P- Value OR  (95% CI) 
1 94 (94%) 7 (6%) 116 (94%) 7 (6%) 0.70 0.81 (0.2-2.3) 
2 75 (83%) 15 (17%) 81 (64%) 45 (36%) 0.002 2.7 (1.4-5.3) 
3 39 (41%) 56 (59%) 43 (35%) 80 (65%) 0.35 1.2 (0.74-2.2) 
4 47 (48%) 50 (52%) 58 (47%) 65 (53%) 0.84 1.0 (0.61-1.7) 
5 29 (29%) 71 (71%) 21 (13%) 107 (87%) 0.02 2.08 (1.1-3.9) 
6 18 (19%) 85 (81%) 10 (8%) 121 (92%) 0.02 2.5 (1.1-5.8) 
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Table 3-6 showing the differing advice given in various clinical vignettes depending on the number of 
patients seen per month by the health care professionals 
 
Vignette > 5/month 
“Can Drive” 
> 5/month 
“Cannot Drive” 
< 5/month 
“Can Drive” 
<5/month 
“Cannot Drive” 
P- Value OR (95% CI) 
1 238 (95%) 13 (5%) 154 (92%) 12 (8%) 0.38 1.4  (0.6-3.2) 
2 183 (87%) 57 (13%) 108 (64%) 59 (36%) 0.01 1.7  (1.1-2.7) 
3 110 (45%) 136 (55%) 63 (37%) 108 (63%) 0.10 1.3 (0.9-2.0) 
4 121 (49%) 128 (51%) 94 (53%) 84 (47%) 0.39 0.8  (0.5-1.2) 
5 64 (25%) 193 (75%) 36 (20%) 148(80%) 0.18 1.3  (0.8-2.1) 
6 41 (15%) 225 (85%) 16 (8%) 168 (92%) 0.03 1.9 (1.0-3.5) 
                                               
3.8.3.4- Age 
The advice given to the patients was not dependent on the age of the clinicians. This 
was not significant in all the vignettes (Table 3-7). 
        Table 3-7 showing no difference among the age group of the clinicians and the advice given  
Vignette-1 Less than 35 Years 36-50 Years More than 50 Years P- Value 
Can Drive 95 (98%) 94 (92%) 91 (93%) 
0.16 
Cannot Drive 2 (2%) 8 (8%) 7 (7%) 
Vignette-2     
Can Drive 69 (76%) 69 (69%) 70 (73%) 
0.56 
Cannot Drive 22 (24%) 31 (31%) 26 (27%) 
Vignette-3     
Can Drive 41 (44%) 42 (42%) 35 (36%) 
0.51 
Cannot Drive 52 (56%) 59 (59%) 62 (64%) 
Vignette-4     
Can Drive 52 (54%) 53 (51%) 56 (56%)  
0.81 
 
Cannot Drive 45 (46%) 50 (49%) 44 (44%) 
Vignette-5     
Can Drive 23 (23%) 23 (22%) 25 (25%) 0.88 
 Cannot Drive 76 (76%) 82 (78%) 76 (75%) 
Vignette-6     
Can Drive 15 (16%) 14 (13%) 10 (10%) 
0.42 
Cannot Drive 85 (85%) 93 (87%) 93 (90%) 
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3.8.4- Advice given following treatment with CPAP 
210 (45%) of clinicians completed forms for the DVLA. 32 responses were excluded 
as the questions were unanswered or were incomplete leaving 178 responses for 
analysis. 
 
 3.8.4.1- Residual Drowsiness  
The DVLA forms enquire whether the patient still suffers from “irresistible” (SL2C) or 
“excessive” (SL2VC) drowsiness. There was inconsistency in the assessment of 
residual drowsiness when completing the form. The advice depended on the choice 
of words “irresistible” and “excessive” on the DVLA form. In each vignette the same 
clinician was more likely to say “yes” to “excessive” than to “irresistible” (71+/12% v/s 
42+/-10%, P-0.0045) (Table 3-8). 
 
3.8.4.2-CPAP Compliance 
Across the vignettes there was a disagreement between clinicians regarding what 
constituted adequate compliance with CPAP (Figure 3-2); “yes” responses ranged 
from 13% to 64%. 
55 
 
Table 3-8 showing the key factors in the vignettes of patients after CPAP treatment and the McNemar’s test showing 
significant variability in what a patient will be told by the same clinician depending on whether the DVLA form asks about 
“irresistible” or “excessive” drowsiness 
 
Vignette   Pre CPAP  
  AHI 
Pre CPAP 
 ESS 
 Post  CPAP 
  AHI 
Post  CPAP 
 ESS 
CPAP use          Other factors “Excessive” 
      “Yes” 
“Irresistible” 
     “Yes” 
       McNemar’s Test 
  P-value     OR (95% CI) 
     7      35/hr      22      10      14  3.2 hr Had stopped driving (his decision) but has now restarted      116(65%)       46(26%)   <0.0001     6.8(3.7-13.7) 
     8      28/hr      15        3       5  6 hr Does not use CPAP during weekend      94 (53%)        69(39%)     0.0009      2.3 (1.4-4.1)     
     9      45/hr      14        7       9  4 hr Does not use CPAP for 2 days in a week     128(72%)        92(52%)    <0.0001       2.7 (1.6-4.7) 
     10      80/hr       22       10      12   N/A No longer having any problems driving but continues to fall asleep  
 watching television, while reading and if a passenger in a car.    
    140(79%)         77(43%)     <0.0001       6.7(3.5-14)     
     11     35/hr       13       Nil      12    N/A Intolerant to CPAP,  lifestyle modifications,  weight loss 4 kilograms     151(85%)          87(49%)     <0.0001        13.8 (5-43)     
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Figure 3-2 showing the disagreement between clinicians regarding adequate CPAP 
compliance 
 
3.8.5- Drivers reported to the DVLA 
131 (74%) of the clinicians who completed the DVLA form had never reported 
patients to the DVLA, 42 (23%) had reported 1-4 times and 5 (3%) had 
reported more than 5 times.  
3.8.6- Influence of sleepiness in different situations  
Respondents were asked to weigh the value given to ESS, description of 
general sleepiness and sleepiness specifically whilst driving when assessing 
a patient’s fitness for driving. On average clinicians gave equal importance to 
all three but with a wide range (Table 3-9) 
Table 3-9 showing the influence of sleepiness contributing to the clinicians’ assessment of 
driving fitness in OSAS patients 
 
 Median Inter Quartile Range          Range 
                    ESS     3               2-4           0-10 
      General Sleepiness    3               2-4           0-7 
 Sleepiness whilst Driving    3               2-4           0-7 
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3.8.7- Use of Objective Tests 
1% of clinicians always and 4% frequently use objective tests to help in their 
assessment. Professional drivers are more likely to undergo objective tests 
than non professional drivers (52% v/s 38%, P-0.0002, OR-1.75) (Table 3-10). 
Table 3-10 showing the current practice of using objective tests by the clinicians’ prior giving 
advice to patients regarding driving  
 
 MSLT MWT OSLER DADS 
Never 123 (69%) 133 (75%) 131 (74%) 165 (93%) 
Occasionally 52 (29%) 39 (22%) 39 (21%) 11 (6%) 
Frequently 3 (2%) 4 (2%) 7 (4%) 2 (1%) 
Always 0 (0%) 2 (1%) 1 (1%) 0 (0%) 
     
 HGV Taxi High mileage Others 
Never 79 (44%) 92 (52%) 107 (60%) 113 (63%) 
Occasionally 62 (35%) 53 (30%) 52 (29%) 49 (27%) 
Frequently 17 (10%) 16 (9%) 8 (4%) 8 (5%) 
Always 20 (11%) 17 (9%) 11 (7%) 8(5%) 
 
MSLT- Multiple Sleep Latency Test, MWT- Maintenance of Wakefulness Test, OSLER- Oxford Sleep Resistance, 
DADS- Divided Attention Driving Simulator  
 
 
3.8.8- Qualitative analysis 
Seventy nine (38%) of respondents provided additional information. Forty 
(50%) were sleep consultants, representing the most experienced clinicians. 
Most responses related to the complexity of the issue of driving and OSAS 
and where the responsibility lies in negotiating this challenge, with the role of 
DVLA, clinician and patient all discussed.  
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3.8.8.1- Understanding current DVLA guidance 
Twenty six respondents commented on the complexity of advising OSAS 
patients about driving. Responses were about the guidance provided by the 
DVLA and views about its usefulness were divided, even amongst 
experienced sleep specialists. A few sleep consultants felt the guidance was 
adequate, but most viewed it as open to interpretation. Others felt it placed 
too much responsibility on health professionals, a view echoed by non-
specialist consultants and trainees who a found advising patient not to drive 
was stressful as they felt guidance was not clear.  
 
Terms such as ’pragmatic’, ‘common sense’ and ‘proportionate’ were used by 
experienced sleep consultants to describe their approach, which  considered 
the patient’s lifestyle, vocation and symptoms. Some sleep consultants 
expressed the view that less experienced physicians were more likely to be 
‘harsher’ than more experienced colleagues. In contrast, some non sleep 
specialists felt that some sleep consultants do not take the problem seriously 
enough; a view echoed by a small number of sleep consultants who 
expressed the opinion that much stricter, standardised, guidance is needed.  
“The medico-legal frame is currently flimsy and inadequate to the point neither 
patients, community nor sleep specialists are properly informed and duly 
protected” (Sleep Consultant).  
“The DVLA guidelines are rather open to interpretation. Devolving the 
responsibility to the clinician caring for the patient to give his/her interpretation 
of the DLVA’s advice is not good enough” (Trainee).  
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3.8.8.2- Responsibility 
The issue of responsibility appeared repeatedly; 55 respondents mentioned it 
and 21 provided a clear statement of their views. It was broadly agreed that it 
is the doctor’s responsibility to advise the patient of the DVLA rules about 
driving and OSAS. However, most felt non-compliance was high and views 
about how to manage this and whose responsibility it is to manage this varied. 
Although few had reported patients to the DVLA, others had used this as a 
threat if the patient did not stop driving.  
 
“DVLA tell us they want everyone to notify them of a new diagnosis and that 
it’s up to them to say if they can drive or not – not us!” (Sleep Consultant) 
“The medical professional is not facing up to our responsibility to protect the 
public from drivers who are not fit to drive. “ (Sleep Consultant).  
Persuading patients to report their diagnosis to DVLA was challenging; some 
tried to couch their advice in terms of doing what is morally right, others 
appealed to the patient’s sense of responsibility.  
“I take the view that this is an issue of individual responsibility and stress this 
to patients, explaining the serious consequences to them and others if they 
get it wrong” (Sleep Consultant). 
 
Although the responsibility not to drive was seen to rest with the patient, 
respondents were concerned if patients had an accident whilst driving  
Clinicians reiterated the importance of ensuring patients are aware of their 
responsibility; and used letters and leaflets to back up their advice. However, 
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many said that documenting advice in this way was a way of defending 
themselves from criticism. 
“[I]insist on the patient reporting to the DVLA, even though I know they often 
don’t, makes me feel like I have covered my tail” (Sleep Consultant). 
 Whilst respondents agreed they would advise professional HGV/PSV drivers 
not to drive until they received treatment and were stable, there was less 
consistency when it came to people who rely on their cars for other reasons. 
“[I have]… mentioned to HGV drivers and a train driver that I would consider 
reporting them” (Sleep Consultant). 
“can be damaging to stop driving in someone whose livelihood may depend 
on it (salesman or driving to work). Obviously need stricter controls for 
vocational drivers” (Non-Sleep Consultant). 
 
3.8.8.3- Dealing with patients sensitively 
The need to deal with patients sensitively and not penalise them for seeking 
help was viewed as vital. There was a tension between a physician’s 
responsibility to advise patients not to drive, and keeping them in treatment. 
Many felt that being too prescriptive would be counter-productive and 
discourage some patients from seeking treatment. A few were of the opinion 
that they would be prepared to advise patients not to drive until treated if they 
could start treatment immediately.  
“It is frustrating that patients who have had this for months (or more likely 
years) are penalised and a more supportive approach is often helpful in 
practice. However, that leaves the patient in the position of driving illegally” 
(Consultant) 
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3.8.8.4- Assessment and Treatment 
Ten respondents specifically discussed concerns about a lack of reliable, 
objective measures of sleepiness and many mentioned this in passing. The 
ESS was viewed as too easy for patients to manipulate and many of the 
objective tests, whilst viewed as more reliable are often only available at 
specialist or tertiary centres requiring referral, and potential delay.   
“I do think it would be useful if the DVLA had a robust, objective scheme for 
assessing vigilance […] it is very hard to deprive someone of their livelihood 
without something objective” (Sleep Specialist).   
                                                                  
3.9- Discussion 
This survey has shown that there is considerable variability in clinician’s 
opinions regarding whether a patient with OSAS should drive or not. The 
vignettes were deliberately chosen to be contentious; less variability may 
have been seen if less contentious vignettes had been presented. However all 
were within the range of what is seen regularly in sleep clinics. There can be a 
wide range of opinion, even about issues that may not appear contentious. 
This is also true in the healthcare arena [108] where attempts have been 
made to reduce variability by the development of guidelines, care pathways 
and protocols and these have been shown to improve outcomes [109]. When 
possible they are based on evidence but in the absence of evidence; expert 
consensus. The results of this survey, particularly the qualitative analysis of 
free text, suggest that consensus may be difficult to achieve. Clinicians do not 
appear to differentiate between sleepiness generally and specifically while 
driving. Despite the fact that ESS correlates poorly with road accidents and 
performance on driving simulators, it is still considered in the decision-making 
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process.  
Objective tests are seldom used and while it could be argued that this is 
because of lack of access there is little evidence that these tests are useful in 
determining whether a patient is safe to drive or not. When they were used, 
the most common was the MSLT, which although an objective tests of 
sleepiness has little relationship to driving. The MWT or the behavioural 
alternative the OSLER test is more logical ; a pathological MWT is associated 
with simulated driving impairment- very sleepy and sleepy patients had more 
inappropriate line crossings than control drivers (P= < 0.05) [73].  In a small 
study comparing patients with untreated OSAS and controls, the number of 
inappropriate line crossings correlated with MWT scores (r2= -0.339; P= < 
0.05) [72]; however this is not sufficiently discriminating for everyday practice. 
The lack of reliable objective tests means that the clinician is dependent on 
the account given by the patient; fear of losing their licence may lead them to 
underplay symptoms. The DVLA is the ultimate arbiter of whether an 
individual can hold a licence or not. What constitutes adequate compliance 
with CPAP and residual drowsiness are both contentious, however there is 
some evidence to suggest adequate compliance if the mean CPAP usage is 
more than 4 hours per night for more than 70% of nights [110]. Clinicians are 
more likely to consider drowsiness “excessive” (vocational form) than 
“irresistible“(standard form) consistent with a higher standard being applied to 
vocational drivers, as intended by the DVLA. However the DVLA is also 
concerned specifically with sleepiness while driving (personal 
communication); a number of vignettes (7, 9, 10 and 11) were of patients with 
general sleepiness, but who denied problems while driving. Many clinicians 
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appear either to be answering the question about residual drowsiness literally 
or do not believe the patient; these questions could be improved by including 
the words “while driving”. 
 
3.10- Conclusion 
The current DVLA and EU statements are discussed in Chapter-1. Clinicians 
want better guidance from the DVLA. This must include clear definitions of 
residual sleepiness, that the key issue is of whether persists during driving, 
and what is meant by adequate compliance. Research needs to be directed 
towards a better understanding of what factors in OSAS impair driving 
performance, how these can be assessed and the development and use of 
objective tests which can inform decision-making and lead to greater 
consistency in the decisions reached. If not patients will lose confidence in a 
process that is inconsistent and therefore unfair.  
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                              Chapter-4 
 
Sleepiness at the wheel, real and simulated 
driving in untreated male Obstructive Sleep 
Apnoea Syndrome (OSAS) patients and 
controls; what is normal?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
65 
 
 
4.1- Abstract 
Advising patients with OSAS about driving is challenging. By integrating self-
reported measures of sleepiness, safety-critical driving incidents and 
performance on a driving simulator task in male controls and untreated male 
OSAS patients we have established what constitutes “normal”. 129 untreated 
OSAS patients (Age= 53 + 12 years, ESS= 14 + 5, ODI= 41 + 26 dips/hour, 
BMI= 36 + 8 kg/m2, driving license years= 31 + 12) and 79 controls (Age= 56 
+ 15 years, ESS= 4 + 3, BMI= 28 + 8 kg/m2, driving license years= 34 + 17) 
completed a driving questionnaire prior to a simulator session. Questionnaire 
responses, simulator outcome and various continuously measured variables 
were compared between the two groups. OSAS patients, but no control 
reported episodes of nodding (> 2 times), admitted to high chance of 
sleepiness while driving and a DSS of more than 7. All controls completed the 
simulator test and none had an unprovoked crash whereas 11% of OSAS 
patients had an unprovoked crash and 9% were unable to complete the test. 
SDLP, a marker of poor driving performance was significantly worse in the 
OSAS group as compared to controls (P= 0.03, 95% CI= 0.0043 to 0.0095) 
and this predicts MUoLDS failure. The group at risk can be identified by key 
questions about sleepiness during driving, real driving incidents, driving 
sleepiness score, simulator outcome and outputs from an advanced PC 
based simulator. Defining what constitutes “normal” and risk stratification 
based on various parameters holds promise and may aid the clinician in better 
decision making. 
 
 
66 
 
4.2- Introduction 
Patients with OSAS are at increased risk of being involved in a RTA because 
of increased sleepiness and poor concentration. However RTAs are not the 
sole preserve of patients with OSAS and not all patients are unsafe drivers.  
Clinicians are often asked to make recommendations about fitness to drive 
and many find this challenging [111]. There is considerable variation in the 
advice that a patient is likely to receive [112]. Guidelines [48, 49] are largely 
based on expert opinion and there is a need for more evidenced based 
recommendations. Although there is a trend towards increased likelihood of 
accidents with more severe sleep-disordered breathing (SDB), the 
relationship is not sufficiently robust on which to base decisions about driving 
for an individual [59]. Furthermore there are conflicting data about the 
relationship between perceived sleepiness and the likelihood of being 
involved in an RTA [31,113]; Sleepiness specifically while driving rather than 
in general, is a better predictor of which OSAS patients are at increased risk 
of RTAs [67]. There are also conflicting data about the relationship between 
objective tests for increased daytime sleepiness and driving [70,114,115].  
 
The Institute for Transport Studies at the University of Leeds, UK has 
developed a sophisticated fully immersive driving simulator (UoLDS). 
Alongside this full-scale simulator, a PC-based mini simulator has been 
developed using the same software (MUoLDS). In a previous study over 50% 
of patients with significant OSAS, sufficient to warrant a trial of CPAP 
completed approximately one hour of “motorway driving” without incident [83] 
suggesting that it is a more credible reflection of driving and by using standard 
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deviation of lane position (SDLP) a subset of patients with OSAS who failed a 
simulated driving test could be identified. A normal range for sleepiness while 
driving and driving simulator performance particularly based on SDLP and 
other continuously measured variables have not been described. Furthermore 
the criteria used to indicate “fail” in the previous study [84], while intuitively 
reasonable, need to be validated against a control group.  
 
4.3- Aims 
The aims of this exploratory cohort study were to define a normal range in 
controls and to compare them with a group of untreated OSAS patients 
against this in the following domains:  
 Self-reported sleepiness while driving 
 Safety – critical driving incidents  
 MUoLDS performance  
 
4.4- Methods 
Patients attending the sleep clinic at St. James’s University Hospital with a 
confirmed diagnosis of OSAS [Apnoea Hypopnea Index (AHI) of > 10 hour 
and/or Oxygen Desaturation Index (ODI) of 4% dips in saturation >10/hour] on 
respiratory variable overnight sleep study (Embletta, Resmed; Abingdon, 
Oxford) or overnight oximetry and who drove regularly with a full valid UK 
driving licence were approached. Majority (n=110, 85%) of OSAS patients 
had a sleep study and the rest (n=19, 15%) had an oximetry. All OSAS 
patients who had an oximetry had moderate to severe sleep disordered 
breathing. The study was exclusively focused on males because in a previous 
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study significant difference in MUoLDS performance was found between the 
genders [31]. Subjects with no symptoms of OSAS and with an ESS of < 10 
were recruited as controls. Participants who were taking sedating medications 
were excluded. Participants in both groups were provided with an information 
leaflet and written consent was obtained. The MUoLDS runs were done 
during the day between 0900-1700 hours. Both the practice and the test runs 
were done in a single sitting. The MUoLDS has been validated by a study 
done by Ghosh et al [84]. Ethics approval for this study was obtained from the 
NHS Research Ethics Committee (09/H1311/58). 
  
4.4.1- Inclusion and exclusion criteria for the study 
The inclusion and exclusion criteria for this study are listed below. 
Inclusion Criteria 
 Age more than 18 years 
 Males 
 Should possess a full valid UK driving licence 
 Previous experience of driving on a UK motor way 
 Able to drive on an automatic mode for more than an hour on the 
MUoLDS 
 Able to consent 
 Documented evidence of OSA either on an overnight oximetry and or a 
home variable sleep study 
 ESS of more than 10 
 No previous CPAP treatment 
 No regular use of sedatives or stimulants 
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Exclusion Criteria  
 Females 
 Unable to consent 
 Non OSA sleep disordered breathing 
 Previous diagnosis of OSA and or previous use of CPAP 
 ESS of less than 10 
 No previous experience of UK motor way driving 
 Having a provisional driving licence  
 Use of sedation or stimulants 
 Unable to drive for more than an hour on the MUoLDS 
 
4.4.2- Scoring of Sleep Disordered Breathing 
The overnight oximetry and the home variable sleep study were scored as per 
the American Association of Sleep Medicine scoring Manual [10]. The 
definitions for scoring are as follows 
 Apnoea – 10 seconds or more duration of 90% or more flow reduction 
 Obstructive apnoea – 10 seconds or more duration of 90% or more 
reduction in flow with effort being made to breathe 
 Hypopnoea- 10 seconds or more of a 30% reduction in flow and effort 
with a 3% or more dip in desaturation 
 Oxygen desaturation Index- 4% dip rate with severity classifications 
similar to Apnoea/Obstructive hypopnoea. The classification is shown 
in 4.4.2.1 sub section. 
 
4.4.2.1- Severity classifications 
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 0-5 events/hour - Normal 
 6-15 events/hour - Mild 
 16-30 events/hour - Moderate 
 More than 30 events/hour - Severe 
 
4.5- Questionnaire 
All completed a questionnaire about sleepiness while driving and whether 
they had an accident, near miss or nodded off at the wheel in the previous 
year. This was developed with the input of patients and healthcare 
professionals and has not been validated. The same questionnaire was used 
in a previous study [84].  All were informed that responses were anonymised 
and would not be used to make fitness-to-drive decisions. Using a four-point 
scale, based on that used for ESS, participants were asked to rate their 
chance of feeling sleepy whilst driving at different times of the day (early 
morning, mid-morning, noon, mid-afternoon, evening and late at night) and 
durations of journey (less than 30 minutes, 30 minutes-1hour, 1-2 hours and 
more than 2 hours). The maximum score was 30 and was termed their 
“Driving Sleepiness Score” (DSS). The fatigue and driving questionnaire is 
listed in appendix III.  
 
4.6- Statistical analysis 
Statistical analysis was carried out using Graph Pad Prism 6 software (San 
Diego, California, USA) and SPSS statistics (Version 24; IBM, New York, 
USA). The level of significance was set at P= <0.05. Unpaired t test was used 
to evaluate for baseline demographics and MUoLDS specific measures 
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between the two groups. To exclude ambiguity, SDLP-3 of more than one or 
infinity were scored as one. Chi-square test was used to evaluate the safety- 
critical driving incidents and MUoLDS performance. Binary regression 
analysis was used for univariate and multivariate analysis to predict MUoLDS 
outcome. Receiver operating characteristic (ROC) curve analysis to calculate 
the discriminative power, positive predictive value (PPV) and negative 
predictive value (NPV) were performed to predict “failure” on MUoLDS. For 
the post hoc analysis, one- way ANOVA with Bonferroni’s multiple comparison 
test (corrected) was used for univariate analysis to evaluate the different 
variables between the high risk, intermediate risk and low risk groups. 
4.7- Results 
4.7.1- Demographics (Table 4-1) 
                             Table 4-1 Demographics: controls and OSAS patients 
 
Mean +/- SD Controls (n=79) Patients (n=129) P- Value CI of difference 
Age (Years) 56 + 14 54 + 11 0.16 -0.97 to 5.8 
ESS 4 + 2 13 + 5 < 0.0001 7.7 to 10.1 
BMI (Kg/m2) 28 + 5 36 + 8 < 0.0001 5.9 to 6.8 
Licence (years) 34 + 17 31 + 12 0.25 -6.0 to 1.8 
ODI  41+26   
 
ESS: Epworth Sleepiness Score, BMI: Body Mass Index (kg/m2), ODI: Oxygen Desaturation 
Index, CI: Confidence interval 
 
Controls and OSAS patients were well matched for age and driving 
experience, but OSAS patients had a significantly higher BMI and were more 
sleepy as evidenced by the higher ESS. 
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4.7.2- Driving Questionnaire (Table 4-2 and 4-3) 
OSAS patients compared to controls admitted to significantly more nodding 
episodes whilst driving, had significantly more near misses, a worse accident 
history and also admitted to more sleepiness while driving. This is shown in 
detail in table 4-3. No control admitted to nodding more than 2 times, high 
chance of sleepiness whilst driving or had a total DSS of more than 7 
compared to 28% of OSAS patients (Table 4-2). A univariate analysis was 
performed between the two groups (Table 4-3). There was a statistically 
significant difference between the percentage of OSAS patients admitting to 
nodding 1 to 2 times, having a near miss or an accident in the last year or to a 
moderate chance of sleepiness while driving than controls. 
                        Table 4-2 showing the DSS between controls and OSAS patients 
 
DSS Controls (n=79) OSAS patients (n=129) 
Score 0 46% (36) 33% (43) 
Score 1-7 54% (43) 39% (50) 
Score more than 7 0% (0) 28% (36) 
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Table 4-3 showing the real time driving events between controls and OSAS patients 
 
                                          
                                       * Minor damage, Major damage, Garage work, Insurance claims in the last one year
Events (In the last one year) Controls (n=79) Patients (n=129) P- Value OR (95% CI) 
 
Nodding (Never) 94% (74) 74% (95) 0.0003 5.2 (1.97 - 14.2) 
Nodding (1-2 times) 6% (5) 17% (22) 0.02 3.0 (1.1 - 8.4) 
Nodding (more than 2 times) 0% (0) 9% (12) 0.003 18.0 (1.0 – 317) 
Near miss 19%(15) 32% (41) 0.04 1.98 (1.0 - 3.8) 
Accident history* 4% (3) 13% (17) 0.02 3.8 (1.0 - 13.5) 
Sleepiness while driving (Never) 49% (39) 34% (44) 0.02 1.8 (1.0 - 3.3) 
Sleepiness while driving (Slight chance) 47% (37) 31% (40) 0.02 1.96 (1.0 - 3.5) 
Sleepiness while driving (Moderate chance) 4% (3) 15% (19) 0.01 4.3 (1.2 - 15.3) 
Sleepiness while driving (High chance) 0% (0) 20% (26) <0.0001 36 (2.4 – 678) 
Driving Sleepiness Score (DSS) < 7 100% (79) 75% (97) <0.0001 53 (3.1- 878) 
Driving Sleepiness Score (DSS) >7 0% (0) 25% (32) 
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4.7.3- MUoLDS outcome (Table 4-4) 
No controls had an unprovoked crash and none were unable to complete the 
simulator run but more crashed at the brake event. In contrast 11% of OSAS patients 
had an unprovoked crash but completed the test; 9% were unable to complete the 
test. No control had an unprovoked crash or was unable to complete the test these 
were considered a “fail” in OSAS patients on the MUoLDS. The MUoLDS outcome is 
shown in table 4.4. 
                Table 4-4 showing the MUoLDS outcome in controls and OSAS patients 
 
Criteria 
 
 
Controls 
(n=79) 
 
OSAS patients 
(n = 129) 
 
P- Value 
 
 
OR (95% CI) 
 
 
Unprovoked crash 0% (0) 11% (14) 0.002 20 (0.002 - 0.85) 
Unable to complete 0% (0) 9% (12) 0.005 17 (0.003 - 1.01) 
< 95% in lane-2 3 % (2) 4% (5) 0.6 1.5 (0.12 - 3.4) 
Veer- event crash 5% (4) 10% (13) 0.2 2.1 (0.66 - 6.6) 
Brake event crash 49% (39) 35% (45) 0.03 1.8 (1.0 - 3.2) 
No events 43% (34) 31% (40) 0.07 1.6 (0.94 - 3.2) 
 
Discriminatory factors between the pass and fail group were evaluated. On 
univariate analysis, ESS, BMI and ODI were significant (Table 4-5).  
                      Table 4-5 showing the univariate variables between the two groups 
 
Variables  
(mean +/-SD) 
“Pass Group”  
(n=103) 
“ Fail Group” 
 (n=26) 
P- Value 
Age (Years) 53 + 11 50 + 13 0.18 
ESS  13 + 5 15 + 5 0.04 
BMI (Kg/m2) 35 + 7 42 + 8 < 0.0001 
ODI  39 + 24 53 + 31 0.01 
Licence (Years) 34 + 17 32 + 12 0.28 
 
BMI-Body mass index, ESS- Epworth Sleepiness Score, ODI-Oxygen desaturation index, DL- Driving 
licence in years 
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 4.7.4- MUoLDS performance based on measured variables (Table 4-6)                    
          
There was a significant difference in SDLP-3 between controls [mean + SD (0.39 + 
0.10), 95% CI (0.37- 0.42)] and OSAS patients [mean + SD (0.44 + 0.18), 95% CI 
(0.41- 0.48)], P= 0.04. 15% of OSAS patients had SDLP-3 more than the 95th centile 
for controls and 9% had SDLP-3 greater than the worst control (figure 4-1).  
          Table 4-6 shows the measured variables between controls and OSAS patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Veer RT- veer reaction time, TTC 3- time to collision in epoch 3, Min Hw- minimum headway, SDLP 3- 
standard deviation of lane position in epoch 3, Brake RT- brake reaction time 
 
            
 
                 Figure 4-1 showing the SDLP-3 between controls and OSAS patients 
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Parameters 
(mean +/- SD) 
Controls (n=79) OSAS patients (n= 129) P= Value 
Veer-RT 1.5 + 0.45 1.5 + 0.57 0.77 
TTC 3 13 + 21 9 + 12 0.12 
Min Hw  3 0.61 + 0.26 0.58 + 0.36 0.47 
HFS 3 0.58 + 0.07 0.57 + 0.07 0.32 
SDLP 3 0.39 + 0.12 0.44 + 0.18 0.04 
Brake-RT 2.9 + 1.4 2.9 + 1.4 0.65 
Speed (miles) 64 + 5 62 + 8 0.07 
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4.7.5- Predictors of MUoLDS failure (Table 4-7) 
Binary logistic regression analysis was performed to predict “failure” on MUoLDS.  
BMI, ESS, ODI and SDLP-3 were significant factors on univariate analysis.  
                             Table 4-7 showing the predictors of “failure” on MUoLDS 
Parameters 
(Unpaired- t test) 
Fail (n=26) 
 
(20%) 
Pass (n=103) 
 
(80%) 
P= Value Mean difference 
Age 50+/-13 53+/-11 0.18 3.4 +/- 2.6 
BMI 42+/-8 35+/-7 <0.0001 - 6.7 +/- 1.5 
ESS 15+/-5 13+/-5 0.04 -2 +/- 1 
ODI 53+/-31 39+/-24 0.01 -14.4 +/- 5.6 
DL (years) 32+/-12 34+/-17 0.28 2.2 +/-1.8 
DSS (Total) 6+/-7 5+/-5 0.41 -1 +/- 1.3 
SDLP-3 0.64 +/-0.21 0.40 +/-0.14 < 0.0001 -0.24 +/- 0.03 
Parameters 
 (Chi-square test) 
   OR (95% CI) 
DSS < 7 69% (18) 77% (79) 
0.43 0.68 (0.26 to 1.8) 
DSS > 7 31% (8) 23% (24) 
No Nodding 77% (20) 73% (75) 0.67 1.2 (0.45 to 3.4) 
Nodding (1-2 times) 15% (4) 17% (18) 0.8 0.85 (0.26 to 2.8) 
Nodding (> 2 times) 8% (2) 10% (10) 0.75 0.77 (0.16 to 3.8) 
Near Miss 42% (11) 29% (30) 0.19 1.8 (0.73 to 4.3) 
Accidents 12% (3) 14% (14) 0.78 0.82 (0.22 to 3.1) 
BMI- Body mass index, ESS- Epworth sleepiness score, ODI- Oxygen desaturation index,  
DL- Driving licence, DSS- Driving sleepiness score,  
SDLP- Standard Deviation of Lane Position( in epoch 3) 
Difference in mean is shown with unpaired t tests and OR (95% CI) is shown with chi-square tests 
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However on multivariate analysis, only BMI (P = 0.008) and SDLP-3 (P = < 0.0001) 
predicted “failure” on MUoLDS. The area under the curve (AUC) was 0.87. This is 
shown in figure 4-2. The positive predictive value (PPV) was 96.30% (95% CI, 
91.24% to 98.48%) and negative predictive value (NPV) was 60.47% (95% CI, 
49.06% to 70.84%). 
        
            Figure 4-2, showing the Area under Curve (AUC) in predicting MUoLDS failure 
                  
4.7.6- Defining criteria to identify the “at risk driver” (Risk stratification) 
I defined “flags”, based upon comparisons with controls, to stratify patients driving 
risk (Tables 4-8 and 4-9). Red flags were factors that were not seen at all in controls, 
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amber flags were seen in some controls but patients were statistically significantly 
worse. 
4.7.6.1- Red flags / High risk group (Table 4-8) 
                                   Table 4-8 Red flag criteria 
1 Admitting to nodding at the wheel 2 or more times in the last year 
2 Admitting to high chance of sleepiness while driving 
3 Driving Sleepiness Score of more than 7 
4 Failure to complete the MUoLDS  test run 
5 Unprovoked crash on the MUoLDS 
6 SDLP-3 greater than 0.66 
 
4.7.6.2- Amber flags / Intermediate risk group (Table 4-9) 
                                       Table 4-9 Amber flag criteria 
1 Admitting to nodding at the wheel 1-2 times in the last year 
2 Accident history or a near miss in the last year 
3 Moderate chance of sleepiness while driving 
4 SDLP-3 more than 0.59 ( 95th percentile) and below 0.66 
 
On multiple comparison testing (Bonferroni’s) there was a significant difference 
between the high risk and the other two groups but not between the group with 
intermediate risk and the group with the same risk as the control population. BMI and 
ESS were significantly worse in the high risk group as compared to the other groups 
(Table 4-10). 
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                       Table 4-10 showing the various variables between the three groups 
Univariate Analysis 
(mean +/-SD) 
 
High risk 
(n=55) 
(43%) 
Intermediate  risk 
(n=54) 
(42%) 
Low risk 
(n=20) 
(15%) 
P- Value 
(One-way 
ANOVA) 
Age 51+11 53+12 56+11 0.26 
BMI (Kg/m2) 39+8 34+6 34+8 0.001 
ESS  16+-5 12+5 12+4 <0.0001 
ODI 46+-28 37+25 38+20 0.16 
   
           BMI-Body mass index, ESS- Epworth Sleepiness Score, ODI-Oxygen desaturation index 
 
           
 
4.8- Discussion 
 
Ideally accident risk should be predicted using an objective test; the limitations of 
self-reporting, particularly when the licence may be at risk, are well recognized [37]. 
However this is always likely to be difficult in a condition which is variable; even 
patients who fall asleep during real driving and have an accident will have been 
driving, often for prolonged periods, on many other days, without incident. It is 
therefore not surprising that I was not able to demonstrate a relationship between 
failure on the simulator and real life events. However I was able to demonstrate, in a 
test which is a more credible test of the ability to maintain alertness while driving 
than for instance the MWT [73] that a subset of patients with OSAS performed 
differently to control subjects.  This study confirms the findings of a previous study 
[84] that over 50% of patients were able to drive for approximately one hour without 
incident. Furthermore I have shown that there was a difference in SDLP in epoch 3 
between patients and controls and there were a significant number of patients with 
values much worse than controls. SDLP has the advantage that it is measured 
continuously, has been shown to predict task failure accurately on the MUoLDS [84] 
and it, or a similar measure, has been shown to indicate the at risk driver in other 
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studies [75,116]. The brake event at the end of the drive was designed such that 
even controls would find it difficult to avoid a crash and indicated the end of the test. 
That more controls than patients failed the brake event is surprising, but patients 
who had had an unprovoked crash, failed to complete the test or the veer event did 
not reach the brake event. It is possible that had they got to the end of the test most 
of these would also have failed the brake event. If available sophisticated PC based 
simulators with realistic graphics may be of some help in indicating which patients 
are not safe to drive, but further work needs to be done before these can be 
considered robust enough for routine clinical use. My data suggest that patients with 
severe OSA, very high BMI and a high ESS (Table 4-10) who deny problems driving, 
or those, in whom there is concern, should be tested on such a simulator. Failure to 
complete, an unprovoked crash or high SDLP should be taken as evidence to 
support recommending that driving cease. Accepting the limitations of self-reporting 
it will always be important even if a robust objective test becomes available; however 
many patients are honest and if they admit to high risk driving behaviour they should 
cease driving regardless of the results of any other tests. Any driver may experience 
sleepiness while driving and it is important to understand what is “normal”. I have 
suggested factors that indicate that an individual differs markedly from controls 
indicating potentially unsafe driving. Red flags were those factors which were not 
seen at all in controls and amber those where there was a statistically significant 
difference between patients and controls. These were defined post hoc. As with the 
use of symptoms to indicate the likelihood of cancer these should not be used in an 
all or nothing way. The circumstances surrounding an event are important; for 
instance the significance of haemoptysis in a non-smoking young individual, with 
frequent nosebleeds, is very different to that when it is seen in a middle aged 
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smoker, occurring persistently over time. In the same way an episode of nodding at 
the wheel after a very long journey has a different significance to nodding repeatedly 
during short journeys. Similarly accidents, and near misses, may not be the fault of 
the individual, nor attributable to sleepiness. However the attribution of “fault” is not 
straight forward either. While there are clearly some situations in which the driver 
cannot be blamed, for instance an individual parked by the roadside and hit by 
another car, there are many when both drivers feel that the accident was not their 
fault. The same is true with regard to what constitutes a “near miss”. The 
questionnaire did not allow participants to provide any further information; I did not 
want events to be dismissed that they considered, erroneously, to not be their fault. I 
suggest that the “flags” that my study has identified are important questions to ask; 
positive answers to any raise concerns about that individual’s continued driving, but 
do not of themselves suggest that driving must cease. Negative responses however 
should not be taken to indicate that the patient does not have a problem. This is a 
situation common to many other aspects of medicine. 
 
The “likelihood” of sleepiness is subjective; one person’s “high” is another’s 
“moderate” chance. However nodding at the wheel is an all or nothing phenomenon; 
an individual either has or has not nodded at the wheel Nodding at the wheel 
indicates that the driver has fallen asleep, albeit transiently; a few seconds longer 
and an accident is likely. It also shows that the individual has made an error of 
judgement by continuing to drive despite increasing sleepiness; accidents due to 
driver sleepiness are always preceded by a period of time when the individual is 
fighting sleep [117]. However patients involved in an accident, when it is likely that it 
is due to them falling asleep at the wheel may deny this either because they do not 
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recall doing so or because they understand the implications of admitting such [118]. 
The same may be true with regard to admitting to nodding at the wheel; however a 
positive response to this question, particularly more than twice in the last year, 
indicates a high risk driver. The questionnaire relies upon an individual telling the 
truth and patients may underestimate or deny problems. Patients are more likely to 
answer an anonymous questionnaire truthfully and the data presented here are more 
likely to represent the true situation, but the possibility that individuals were not 
truthful, or underestimated their symptoms, cannot be discounted. My data shows 
that as compared to controls, untreated male OSAS patients report frequent nodding 
more than 2 times in the last year (OR= 18), near miss (OR=2), history of accidents 
(OR=3.8) and admit to high chance of sleepiness (OR= 36). This is consistent with 
other case control and population based studies (Table 1-1, Chapter-1). When 
discussing driving restriction patients sometimes state “everyone struggles to stay 
awake driving occasionally” or similar and challenge the advice.  Any sleepiness at 
the wheel is potentially dangerous and is unacceptable; these data justify restricting 
driving in certain OSAS patients by showing them that their sleepiness is not 
“normal”. My data also indicate which patients, who deny problems driving, should 
be tested upon an advanced PC-based driving simulator and criteria on which they 
should then be advised not to drive. 
 
4.9- Study limitations 
This study focused only on males. A previous study has shown that MUoLDS 
performance and task failure is gender dependent [119]. It is likely that the 
questionnaire responses are still valid in females, but this will need to be confirmed 
in future studies. I only studied patients with OSAS of sufficient severity to warrant a 
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trial of CPAP; this is the group in which a risk assessment needs to be made about 
an individual’s continued driving. It would not be appropriate to say that someone did 
not have OSAS of sufficient severity to warrant treatment but severe enough that a 
patient should not drive. Annex III of the European Union (EU) Directive on Driving 
Licences, states that patients with OSAS, needing treatment in the opinion of a 
physician and not receiving it, should not receive an unconditional licence [51]. 
However this study needs to be extended to patients with milder OSAS, as they may 
still be at increased risk of an accident. I did not perform sleep studies in controls. 
However the questionnaire included questions about symptoms of snoring or OSA 
and controls were only included if they had a low probability for OSAS. I think it is 
very unlikely that I included any controls with significant OSAS and the results of the 
driving simulation and the questionnaire would support this. I only used data from the 
third epoch as a previous study showed that on average this is representative of the 
whole study. However it is possible, on an individual basis that more detailed 
analysis including other epochs may pick up other at risk drivers. The driver seat 
used was not a standard driving seat and thus some patients may have found it 
cumbersome whilst driving (personal feedback) and thus may have had issues with 
accelerator and brake pedals. This may have impacted upon the reaction times and 
outcome. Finally seeking information from licensing authorities or police has 
limitations also as not all accidents, and certainly not near misses or episodes of 
nodding at the wheel, are reported. 
  
4.10- Conclusion 
In common with many other situations in medicine a decision about whether an 
individual should cease driving is complex and cannot be based on simple yes or no 
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criteria. I suggest several factors, each of which needs to be weighed for 
significance. Licensing authorities remain the final arbiter of who should cease 
driving but they should be guided by clinicians. Individuals should be advised of their 
personal responsibility; they may be safe to drive most of the time, but not after a 
poor night’s sleep. No one should drive if they cannot guarantee to maintain full 
concentration and vigilance. Advanced PC based driving simulators have a role in 
identifying the at risk driver, but further research is required. 
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                                    Chapter-5 
 
A randomised trial evaluating the issue of 
repeatability and the effect of incentives on an office 
based advanced driving simulator (MUoLDS) in 
OSAS patients 
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5.1- Abstract 
On average, patients with OSAS are at higher risk of being involved in road traffic 
accidents. No objective tests have been shown to predict reliably whether an 
individual is safe to drive or not and there is significant variation in the advice given 
by the clinicians. Using continuously measured variables in an advanced PC-based 
driving simulator the at risk patients can be identified with a high degree of accuracy. 
Individuals may “raise their game” if they know that their licence is at stake. 150 
untreated OSAS patients (males-131) were randomised to either test repeatability 
(n=50) or the effect of an incentive (n=100). All performed a simulator run, after initial 
acclimatisation. For the repeatability test, patients performed the simulator run on 
two separate occasions; they were not informed about how well they had performed 
during the test. To test the effect of an incentive patients again performed the 
simulator run on two separate occasions but just prior to the second run they were 
told they would be given a prize if they could improve their performance by 10%. 
SDLP in epoch 3 and “veer” reaction time (Veer-RT) were the co-primary outcome 
variables. Classification of patients based on pre-set criteria into "fail" and "pass" 
were the secondary outcome variables.137 patients (repeatability -48, incentive -89) 
completed the trial. The median duration between the two simulator runs was 13 
days (range, 5-55). There was no difference in the SDLP in epoch 3 (P = 0.54, Δ 
change = -0.01) and Veer-RT (P = 0.37, Δ change = 0.13) in the repeatability arm. 
There was no effect of an incentive on SDLP in epoch 3 (P= 0.39) and Veer-RT (P= 
0.15). 67% of OSAS patients passed the MUoLDS on both the occasions, 12% failed 
on both the MUoLDS run. However 21% of OSAS patients either passed on run one 
and failed on run two or the vice versa. Continuously measured variables (SDLP and 
Veer-RT) on the MUoLDS are consistent. There is no effect of a simple incentive; 
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hence no effect on motivation. Although a majority of OSAS patients did not change 
the MUoLDS outcome, one in five patients changed categories from either a pass to 
fail or vice versa.  
 
5.2- Introduction 
Driving a vehicle is a skill that involves complex integrated higher cortical function, 
alertness, concentration and eye to hand coordination [40]. The risk assessment of 
any OSAS patient should include a combination of subjective and objective 
assessment that leads to greater consistency in the decisions reached. An objective 
test should evaluate many aspects of safe driving and thus should aid in the 
decision-making. If the MUoLDS is to be useful in the clinical setting it is important 
that the test should be consistent. A major concern about the use of any test, the 
result of which will be dependent upon the motivation of the subject, is that the 
individual may be able to "raise their game" if their driving licence is at stake. I 
hypothesised that the variables (SDLP in epoch 3 and Veer-RT) recorded on the 
MUoLDS could be repeated on different runs and patients cannot improve the 
simulator performance despite an incentive offer. I have therefore evaluated these 
factors further by conducting a randomised trial. 
 
5.3- Methods 
This was a single centre randomised trial conducted at St James’s University 
Hospital, Leeds, UK. Ethical approval was obtained from the local NHS Research 
Ethics Committee (12/YH/0168). Untreated patients with a confirmed diagnosis of 
OSAS [apnoea hypopnoea index (AHI) and/or oxygen desaturation index (ODI- 4% 
dips in saturation of more than 10/hour) on respiratory variable overnight sleep study 
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(Embletta; ResMed, Abingdon, UK) or overnight oximetry who possessed a full UK 
valid driving licence (Group 1 or Group 2) and who drove on the motorways were 
approached. Patients with nocturnal symptoms and excessive day time sleepiness 
and an ESS of more than 10 were classified as OSAS patients. All patients were told 
not to drink any caffeinated drinks within two hours of the start of the study and all 
completed a driving questionnaire. The MUoLDS practice and test run were done in 
a single sitting between 0900 and 1700 hours on two separate days. 
 
5.4- Study design and randomisation 
The randomisation was done using a computer-generated random number sequence 
for both the arms. The process was supervised by an independent clinical trials co-
ordinator who was not associated with the study. I was completely blinded to the 
randomisation process. Patients (n=150) were randomised into two arms, 
repeatability (n=50) or effect of incentive (n=100) respectively. The sample size was 
based on Martin Bland’s work [120]. To assess the repeatability issue patients 
performed the simulator run on two separate occasions. To assess the effect of a 
simple incentive patients performed the simulator run on two separate occasions but 
just prior to the second run were offered a prize (a gift voucher of £25) if they could 
improve their performance by 10% (in SDLP during Epoch 3). All simulator runs were 
undertaken prior to starting CPAP treatment. The trial protocol is listed in appendix 
IV. 
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5.4.1- Inclusion and exclusion criteria for the study 
The inclusion and exclusion criteria for this study are listed below. 
Inclusion Criteria 
 Age more than 18 years 
 Should possess a full valid UK driving licence 
 Previous experience of driving on a UK motor way 
 Able to drive on an automatic mode for more than an hour on the MUoLDS 
 Able to consent 
 Documented evidence of OSA either on an overnight oximetry and or a home 
variable sleep study 
 ESS of more than 10 
 No previous CPAP treatment 
 No regular use of sedatives or stimulants 
 
Exclusion Criteria  
 Unable to consent 
 Non OSA sleep disordered breathing 
 Previous diagnosis of OSA and or previous use of CPAP 
 ESS of less than 10 
 No previous experience of UK motor way driving 
 Having a provisional driving licence  
 Use of sedation or stimulants 
 Unable to drive for more than an hour on the MUoLDS 
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5.5- Simulator road layout and scenario 
This is described in detail in Chapter 2. 
 
5.6- Measures and end points 
Task failure was defined as unprovoked crash or unable to complete the test. 
Unprovoked task failure and failure to complete the test should not happen during 
normal simulated driving and any subject falling into this category was considered to 
have “failed” the simulator test. Subjects who completed the test or had either a veer 
event crash or brake event crash or spending less than 5% of the study time (2½) 
minutes were deemed to have “passed”. Continuous variable parameters of driving 
behaviour were recorded at 60 Hz and these included SDLP and Veer-RT. 
Definitions of various driving simulator parameters are described in Chapter 2. 
 
5.6.1- Primary Outcome 
SDLP in epoch 3 and “veer” reaction time (Veer-RT) were the primary outcome 
variables.  
5.6.2- Secondary Outcome 
Classification of patients into "Fail" and "pass" were the secondary outcome 
variables.  
 
5.7- Statistical analysis 
The statistical analysis was carried out using Graph Pad Prism 6 software, San 
Diego California USA and SPSS version 20. Statistical significance was set at P= < 
0.05. Data are presented as mean +/- SD. Both in the repeatability and incentive 
arm, SDLP in epoch 3 and Veer-RT in run 1 were compared with run 2 in using 
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paired t tests (2-tailed). The difference in SDLP in epoch 3 and Veer-RT in run two 
were compared between groups A and B, using unpaired t tests (2-tailed) to evaluate 
the effect of incentives. Chi-square contingency test was used to evaluate the 
MUoLDS outcome between run-1 and 2 respectively. Unpaired t tests (2- tailed) and 
Chi-square contingency test were used for post hoc analysis. 
 
5.8- Results 
150 patients were randomised to assessment of repeatability arm (n=50) or the 
effect of an incentive (n=100). 137 patients completed the trial (figure 5-1). The 
baseline demographics of the patients are shown in Table 5-1. The median duration 
between the two runs on the MUoLDS was 13 days (range, 5-55). 
 
                           Table 5-1: Demographics of OSAS patients in the two arms 
 Repeatability Arm (n= 48) Incentive Arm (n= 89) P- Value 
Age (Years) 55 +/- 12 52 +/- 10 0.11 
Males (%) 88% (n= 42) 85% (n= 76) 
 
Females (%) 12% (n=6) 15% (n=13) 
BMI (mean +/-SD) (kg/m2) 36 +/- 7 37 +/- 8 0.5 
ESS (mean+/-SD) 15 +/- 3 16 +/-3 0.16 
ODI (mean +/-SD) 40 +/- 29 38 +/- 23 0.7 
DL (mean +/- SD) (Years) 30 +/- 2 29 +/- 4 0.3 
 
BMI, body mass index; ESS, Epworth Sleepiness Score; ODI, oxygen desaturation index, DL; Driving 
Licence 
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                     Figure 5-1, CONSORT flow diagram of the trial randomisation 
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             Excluded (n=15) 
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         Excluded (n=2) 
  Withdrew consent (n=2) 
 
 
 
 
          Excluded (n=11) 
    Withdrew consent (n=4) 
   CPAP prior to run-2 (n=3) 
      Lost to follow up (n=2) 
       Unable to drive (n=2) 
 
Unable to drive (n=2) 
Run-2  
(N=137) 
 
Repeatability arm (n=48)   
Incentive arm (n=89) 
Incentives Arm 
(N=100) 
Repeatability Arm 
(N=50) 
93 
 
5.8.1- Primary Outcome 
5.8.1.1- Effect of repeatability 
There was no statistically significant difference in the SDLP in epoch 3 and Veer- RT 
during MUoLDS run one and two respectively. The continuously measured variables 
were consistent and thus were repeatable (Table 5-2; figure 5-2 and 5-3).   
         Table 5-2, showing the SDLP-3 and Veer-RT in run one and two (effect of repeatability)          
Variable 
 
MUoLDS- Run 1  MUoLDS- Run 2 Δ change P- Value 
SDLP-3 ( mean +/- SD) 0.45 +/- 0.16 0.44 +/- 0.16 -0.01 0.54 
Veer-RT( mean +/- SD) 1.58 +/- 0.51 1.72 +/- 0.30 0.13 0.37 
                
             SDLP-3, standard deviation of lane position in epoch-3, Veer-RT, veer reaction time. 
 
    
                   Figure 5-2 showing the repeatability of SDLP-3 between the two MUoLDS runs 
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               Figure 5-3 showing the repeatability of Veer-RT between the two MUoLDS runs 
 
5.8.1.2- Effect of incentives 
The difference in the SDLP-3 and Veer-RT between run-1 and 2 in both the 
repeatability and the incentive arms were compared using unpaired-t tests and there 
was no significant difference observed and hence there was no effect of a simple 
incentive (Table 5-3 & figure 5-4 and 5-5). 
Table 5-3, showing the Δ change in SDLP-3 and Veer-RT between run one and run two (effect of 
incentive) 
Arm Repeatability Incentive P- Value 
Δ SDLP 3 (mean +/- SD) -0.01 +/- 0.11 0.01 +/- 0.16 0.39 
Δ Veer RT (mean +/- SD) 0.13 +/- 0.53 -0.12 +/- 0.57 0.15 
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                  Figure 5-4 showing the Δ change in SDLP-3 between the two groups  
 
        
                  Figure 5-5 showing the Δ change in Veer-RT between the two groups  
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5.8.2- Secondary outcome  
There was no statistically significant difference in the MUoLDS outcome between 
run-1 and run-2 respectively (P- value= 0.29, OR= 1.37). This is shown in table 5-4.  
                                    Table 5-4 showing the secondary outcome        
 
Most patients (79%) did not change category between the two MUoLDS outcome but 
a significant proportion (21%) either failed on run-1 and passed run-2 or vice versa. 
This is shown in table 5-5. 
                             Table 5-5 showing the MUoLDS outcome between run1 and 2 
 
                  
 
5.8.2.1- Subgroup analysis (Repeatability and Incentive arm) 
There was no difference in the secondary outcome in either the repeatability or the 
incentive arm. This is shown in table 5-6 and 5-7 respectively. 
 
 
 
 
 
 
Overall Run-1 Run-2 P- Value Odds Ratio 
Fail 18% (n=24)  23% (n= 31) 
0.29 1.37 
Pass 82% (n=113) 77% ( n=106) 
MUoLDS Outcome (Run-1 and Run-2) 
Pass/ Pass 67% (92)  
Fail/ Fail 12% (16) 
Others ( Fail/ Pass or Pass/ Fail) 21% (29) 
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        Table 5-6 showing the sub group analysis of the secondary outcome between the two arms 
Outcome 
Repeatability arm ( n=48)  
P- Value Odds Ratio 
MUoLDS Run-1     MUoLDS Run-2 
Fail 25% (n=12) 29% (n=14)  
0.64 1.2 
Pass 75% (n=36)  71% (n=34)  
    
 
Incentive Arm ( n=89) 
  
MUoLDS Run-1 MUoLDS Run-2 
Fail 13% (n=12)  19% (n=17)  
0.31 1.5 
Pass 87% (n=77)  81% (n=72) 
 
                  Table 5-7 showing the MUoLDS outcome between the two arms in run1 and 2 
Outcome Repeatability Arm Incentive Arm P- Value OR 
Pass/ Pass 63% (n= 30)  74% (n= 66) 0.15 1.7 
Fail/ Fail 17% (n= 8) 7% ( n= 6) 0.06 2.7 
Others 
( Fail/ Pass or Pass/ Fail) 
20% (n= 10)  21% (n= 17) 0.98 1.0 
 
5.8.3- Post hoc analysis 
Although there was no significant difference in the secondary outcome, 1 in 5 OSAS 
patients either pass on run one and fail on run two or vice versa irrespective of the 
randomised arms. Gender has shown to be a factor responsible for simulator 
performance [119] and therefore to evaluate this further I performed a post hoc 
analysis in males and females OSAS patients separately. The results are shown in 
table5-8. There was no statistically significant difference in the baseline 
demographics and in the MUoLDS outcome between males and females. However 
males were more likely to change the outcome (22% versus 10.5%) but this was not 
statistically significant. 
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                      Table 5-8 showing the post hoc analysis between males and females 
 
Males Females 
 Total 86% (n= 118) 14% (n= 19) 
 
Repeatability Arm 36% (n= 42) 32% (n= 6) 
Incentive Arm 64% (n= 76) 68% (n= 13) 
Parameters 
(Unpaired- t test) 
  P- Value 
Mean 
difference 
Age (mean+/- SD) 54 +/- 12 50 +/- 9 0.18 3.6+/- 2.8 
BMI (mean+/-SD) 36 +/- 8 38 +/- 8 0.23 2.1 +/- 1.2 
ESS (mean +/-SD) 13 +/- 5 15 +/- 3 0.11 2 +/- 1 
ODI (mean +/-SD) 40 +/- 25 34 +/- 25 0.31 -14 +/- 5.6 
DL (Mean +/SD) (Years) 30 +/- 2 29 +/- 4 0.3 1.1 +/- 1.2 
Parameters 
(Chi-square test) 
   Odds ratio 
Pass/Pass 66% (n= 78) 79% (n= 15) 0.26 0.52 
Fail/ Fail 12% (n= 14) 10.5% (n= 2) 0.86 1.1 
Others  
( Pass/ Fail or Fail/Pass) 
22% (n= 26) 10.5% (n= 2) 0.24 2.4 
 
BMI, body mass index (kg/m2); ESS, Epworth Sleepiness Score; ODI, oxygen desaturation index, DL; 
Driving Licence 
 
5.8.3.1- Comparing old and new criteria for MUoLDS failure 
In Chapter-4, I have shown that a SDLP-3 of more than 0.66 to be a high risk group. 
However this is applicable only to males as there is no data available regarding the 
normal range in MUoLDS performance in females. Thus I compared the MUoLDS 
outcome based on two criteria’s. 
I. Criteria A- unprovoked crash, unable to complete.  
II. Criteria B- unprovoked crash, unable to complete, SDLP-3 of > 0.66.  
There was no significant difference in the MUoLDS outcome and this is shown in 
figure 5-6. 
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                        Figure 5-6 showing the MUoLDS outcome based on two different criteria 
 
5.8.3.2- Comparing SDLP-3 with MUoLDS outcome on both run-1 and run-2 
In the previous Chapter, I have shown that SDLP-3 is a predictor of MUoLDS 
outcome and hence I compared this with MUoLDS outcome on run-1 and run-2 
respectively. There was no statistically significant difference between the three 
groups. This is illustrated in figures 5-7, 5-8 and 5-9 respectively. The red dotted line 
represents mean SDLP-3 and the green dotted line represents 95th centile in male 
controls.  
I also explored any differences in ESS, BMI, ODI between the MUoLDS outcomes. 
OSAS patients with worse severe SDB, higher BMI and worse sleepiness were more 
likely to either fail on both the runs or fail in run-1 and pass in run-2 and vice versa. 
This is shown in table- 5-9. 
 
66% 
12% 
22% 
66% 
13% 
21% 
0%
10%
20%
30%
40%
50%
60%
70%
Pass/Pass Fail/Fail Others (Pass/Fail or
Fail/Pass)
Criteria A (n-118)
Criteria B (n=118)
100 
 
     
                            Figure 5-7 showing the SDLP-3 in the pass/pass group 
     
                               Figure 5-8 showing the SDLP-3 in the fail/fail group 
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                           Figure 5-9 showing the SDLP-3 in the pass/fail or fail/pass group 
                         
 
                         Table 5-9 showing the baseline differences between the two groups 
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          Parameter  
       Fail/ Fail (n=14) 
       Fail/Pass (n=13) 
       Pass/Fail (n=13) 
 
Pass/Pass 
(n= 78) 
 
P-Value 
Age (mean/SD) 54 (11) 54 (13) 0.72 
BMI (mean/SD) 39 (9) 34 (6) 0.003 
ESS (mean/SD) 19 (15) 13 (5) 0.007 
ODI (mean/SD) 48 (27) 36 (23) 0.01 
Time between run-1 & 2 (median/IQR) 
 
15 days (7-25) 
 
13 days (7-23) 
 
     0.32  
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5.9- Discussion 
Driving is an essential part of modern life and depriving an individual of their licence 
has major potential implications for them and society. Assessing and advising 
whether a patient with OSAS should stop driving is one of the key components in 
management and therefore it is vital to identify accurately the OSAS patient who is at 
risk. To do so any results from a potential objective test should be consistent and 
hence reproducible. It is also true that the general hypothesis regarding the effects of 
monetary incentives on effort and performance is that incentives lead to greater 
effort than would have been the case in their absence. Incentives can serve several 
functions such as initiating action, changing goals and ensuring commitment (121-
123). The main objectives in this randomised trial were to evaluate the test-retest 
reliability in continuously measured variables and to gauge the effect of a financial 
incentive on driving performance on the MUoLDS.  
 
The main outcomes of this randomised trial were the consistency in the 
measurement of continuous variables (SDLP-3 and Veer-RT) on successive runs 
with no effect of motivation factor; hence OSAS patients being assessed could not 
significantly improve the results despite raising the game and the outcome on 
MUoLDS. OSAS patients in both the randomisation arms were matched for age, 
BMI, ESS, severity of OSAS and driving experience. The trial focussed on recruiting 
symptomatic OSAS patients who were more likely at risk of having problems during 
driving. It could be argued that some OSAS patients did raise their game and thus 
did not fail on the second run but there was no improvement in SDLP-3 or the veer- 
RT. This may imply that the continuously measured variable which both the clinician 
and the OSAS patient are oblivious to may be a better marker of risk assessment as 
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compared to the MUoLDS outcome. SDLP3 has the advantage that it is measured 
continuously, has been shown to predict task failure accurately on the MUoLDS [28] 
and it, or a similar measure, has been shown to indicate the at risk driver in other 
studies [22,27]. Ideally an objective test should be used and tests such as the 
divided attention driving simulator while intuitively reasonable surrogates for real 
driving lack credibility.  
 
However a fifth of OSAS patients change category in terms of the outcome of the 
simulator run. The same is also true for SDLP3; on average it did not change but 
patients did move above or below the thresholds we have identified, indicating 
increased risk, between the two studies. One possible explanation could be that this 
is just day to day variability in performance on a simulator.  However this is also true 
of real world driving - the individual who has an accident one day will almost certainly 
have driven before without having had an accident and will drive afterwards without 
having an accident. The performance on the simulator therefore reflects the real 
world. However individuals who have had an accident are more likely to have 
another accident and the patient who fails on the simulator is therefore at increased 
risk as no controls did this. However a pass does not necessarily mean that the 
accident risk is not increased. 
 
OSAS patients who failed the MUoLDS on either of the runs were more sleepy, had 
a higher BMI and had worse SDB as compared to those who passed the MUoLDS 
and this was statistically significant. This suggests that patients with high BMI or high 
ESS or the most severe SDB who pass the test should be considered for retesting, 
perhaps with some sort of distraction task or a drive of longer duration. There is no 
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data available in controls about the issue of repeatability and the effect of incentive 
and further studies are needed to explore this finding. 
 
5.10- Trial limitations 
Apart from the study limitations described in Chapter-4, the specific limitations in this 
trial were that there was no standard time period between the first and second run 
and majority of the patients did their second run on the day of their CPAP trial 
appointment. I did not do a detailed analysis of all the epochs for any change in 
SDLP. Unlike the patients studied in Chapter-4 this study included females and a 
post –hoc analysis showed that males were more likely to change the outcome from 
either a pass to fail or vice versa on successive runs but this was not statistically 
significant.  
    
5.11- Conclusion 
Although the continuously measured variable is repeatable and there is no effect of a 
simple incentive, the hard outcome on MUoLDS based on pre-set criteria is not 
repeatable and a fifth of patients change categories. On an individual basis the 
SDLP3 also changes between runs. Male OSAS patient with higher BMI, worse ESS 
and worse severe SDB may need to repeat the MUoLDS if the clinician’s suspicion is 
high.  
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                                    Chapter-6 
 
Use of fatigue related counter measures (Coping 
Strategies) while driving in male OSAS patients and 
controls 
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6.1- Abstract 
Sleepiness while driving is potentially fatal and it is recommended that a driver who 
starts to feel tired should stop and have a rest, but some may use various counter 
measures to try to stay alert. Using a questionnaire that assessed various potential 
fatigue related counter measures (coping strategies), I explored whether there was 
any difference in those used in the last year between OSAS patients and controls. I 
also compared use with sleepiness generally (ESS), specifically while driving (DSS), 
accident history and the outcome on the MUoLDS. 98 untreated male OSAS patients 
[ESS= 14 +/- 9, BMI = 36 +/- 8, ODI = 41 +/- 25] and 53 male controls [ESS = 4 +/- 3, 
BMI= 28 +/- 5] matched for age and driving experience were recruited. All completed 
a questionnaire, relating to their experience over the last one year, which included 
ESS, DSS, ten questions about various strategies they adopt in order to stay awake 
and their accident history. All performed a 90km motorway driving simulation. Male 
OSAS patients as compared to male controls frequently use coping strategies (46% 
versus 17%, P= 0.0004, OR= 4.1), were more sleepy generally (ESS 17 +/- 3 versus 
12 +/- 5, P= < 0.0001) and were more likely to have clinically significant sleepiness 
while driving (DSS 11 +/- 7 versus 4 +/- 5, P= < 0.0001). 10% of patients who had a 
DSS of less than 7 used 3 or more coping strategies “frequently”. History of 
accidents was significantly higher in patients who used 3 or more coping strategies 
“frequently” (78% versus 45%, P= 0.005, OR= 4.3). OSAS patients report “frequent” 
use of coping strategies and some admit to sleepiness both generally and 
specifically while driving. These counter measures may be surrogate markers of 
fatigue and sleepiness. Asking about such strategies in clinical practice may aid the 
clinician in identifying the at risk patients. 
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6.2- Introduction 
Driving is a complex task that involves many aspects such as perception, response 
time, physical ability and is an essential part of an individual’s life. Studies have 
shown that driving either on a motorway or on an urban road can be fatiguing even 
for an alert driver [117, 124-125]. Driver stress and fatigue may impair performance; 
compromise safety [126] and drivers may adapt various counter measures to tackle 
this issue. A survey among commercial drivers unveiled a series of specific 
responses related to a feeling of excessive sleepiness at the wheel that were not 
usually considered in the medical context. These attitudes served as “alerting 
signals” that the sleepiness level was too high, and that the driver should take a 
break in order to avoid a possible RTA [127]. I hypothesised that asking about the 
use of coping strategies might be another way to identify the OSAS patient at risk of 
RTA. Furthermore while patients might be reluctant to admit to problems driving, 
because of fear that they might be prevented from driving, they might be more willing 
to admit to using coping strategies. This might therefore be a less threatening way of 
identifying the individual who is at increased risk of an accident due to fatigue. It is 
also possible that such strategies might be effective in preventing accidents. 
 
The aims of this study were to identify strategies to counter feelings of fatigue 
employed by OSAS patients and controls and compare the use of these with 
accident history, sleepiness in general and specifically while driving and performance 
on an advanced office based driving simulator. 
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6.3- Methods 
The methodology including the inclusion/exclusion criteria and the scoring for sleep 
disordered breathing has been discussed in Chapter-2. Females were included in 
this study as the main hypothesis was to evaluate the use of fatigue related counter 
measures rather than the MUoLDS outcome or performance. Ethical approval for the 
study was obtained by the NHS Research Ethics Committee - 09/H1311/58. 
6.4- Questionnaire  
All subjects completed a questionnaire about driving and the use of coping strategies 
(listed in appendix III and V). This was developed with the input of patients and 
healthcare professionals. This questionnaire has not been validated. The 
questionnaire included demographic details, ESS; ten questions about various 
counter measures (coping strategies) patients might adapt in order to stay awake. 
Admitting to one or more coping strategies “frequently” was compared between 
OSAS patients and controls. Accident history included nodding events, near miss, 
minor damage and major damage or insurance claims. Questions about sleepiness 
while driving were posed, and following the format of ESS, OSAS patients and 
controls were asked to rate on a scale ranging from “Never” to “High” their chance of 
dozing or falling asleep while driving at different times of the day and on journeys of 
different durations. The maximum score was 30 and gave a Driver Sleepiness Score 
(DSS). This has been discussed in Chapter-4. 
 
6.5- Driving Simulator (MUoLDS) 
All performed a 90km motorway driving simulation after 20 min acclimatisation. The 
simulator outcome was based on preset criteria. The simulator road layout and 
scenario are described in Chapter-2.  
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6.6- Statistical analysis 
The statistical analysis was carried out using Graph Pad Prism 6 software (San 
Diego, California, USA). The level of significance was set at P= <0.05. Normally 
distributed data are presented as mean/standard deviation. Median/Interquartile 
range was used for data that are not normally distributed. Unpaired t-test was used 
to evaluate for subject demographics and for univariate analysis. Chi-square tests 
were used to evaluate the difference in the use of coping strategies between controls 
and OSAS patients and accident history. Spearman correlation was performed to 
evaluate the relationship between ESS, DSS and “frequently” used coping strategies 
as the data was not normally distrributed. One- way Anova and Bonferroni’s multiple 
comparison tests were used to compare the use of coping strategies and the 
MUoLDS outcome and SDLP-3 between the three groups. 
 
6.7- Results 
98 untreated male OSAS patients and 53 male controls were included in the study. 
The baseline demographics are shown in table 6-1. 
               Table 6-1 showing the baseline demographics in OSAS patients and controls 
Parameters( mean +/- SD) Controls (n=53) Patients (n=98) P- Value 
Age  56 +/- 11 53 +/- 9 0.08 
ESS 4 +/-  3 14 +/- 9 <0.0001 
BMI (Kg/m2) 28 +/- 5 36 +/- 8 <0.0001 
Licence (Years) 34 +/- 13 32 +/- 9 0.21 
ODI  41 +/- 25  
 
         ESS- Epworth Sleepiness Scale, BMI- Body mass index, ODI- Oxygen desaturation index. 
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6.7.1- “Frequently” used coping strategies  
OSAS patients were more likely to use at least one coping strategies “frequently” as 
compared to controls and this was statistically significant (46% versus 17%, P value= 
0.0004, OR= 4.1). No control used more than three different strategies as compared 
to 23% of OSAS patients who used more than three such strategies while driving. 
This is shown in figure 6-1. 
 
Figure 6-1- showing the number of “frequently” used coping strategies between controls and OSAS 
patients 
 
6.7.2- Types of “frequently” used coping strategies 
The various types of “frequently” used coping strategies by OSAS patients and 
controls are shown in table 6-2. All were statistically significant except stopping for a 
nap.
0%
2%
4%
6%
8%
10%
12%
14%
16%
1 2 3 4 5 6 7 8 9 10
Controls
Patients
111 
 
 
Table 6-2 showing the types of “frequently” used coping strategies between controls and 
OSAS patients 
 
 
Controls 
 ( n=53) 
Patients 
(n=98) 
P= Value Odds ratio ( OR) 
Stopped for a nap 2% (n=1) 9% (n=9) 0.10 5.2 
Stopped for a walk/ 
exercise 
0% (n=0) 12% (n=12) 0.007 6.8 
Opened the window 13% (n=7) 33% (n=32) 0.01 3.1 
Turned up the radio/ stereo 2% (n=1) 21% (n=21) 0.001 14.8 
Stopped to drink tea/coffee 6% (n=3) 22% (n=22) 0.01 4.8 
Stopped at service area to 
wash face in cold water 
0% (n=0) 12% (n=12) 0.008 15.4 
Sing/talk to yourself 0% (n=0) 13% (n=13) 0.004 16.8 
Chew gum/eat something 0% (n=0) 14% (n=14) 0.005 18.3 
Fidget/ exercise 0% (n=0) 11% (n=11) 0.01 6.6 
Changed seat position 2% (n=1) 13% (n=13) 0.03 7.9 
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A univariate analysis was performed to identify any variables which could 
predict the group of subjects using more than three coping strategies. This is 
shown in table 6-3. 
                Table 6.3 showing the univariate analysis between the two groups 
 
 
 
BMI- Body mass index, ESS- Epworth Sleepiness Scale, ODI- Oxygen desaturation index, 
DSS- Driving Sleepiness Score 
 
 
 
6.7.3- Correlation between “frequently” used coping strategies, DSS and 
ESS 
There was a correlation between “frequently” used coping strategies, ESS 
and DSS. Admitting to general sleepiness, ESS (r=0.37, P= 0.01) (figure 6-2) 
and sleepiness specifically while driving, DSS (r=0.42, P=0.004) (figure 6-3) 
were significant in OSAS patients who admit to using more than three coping 
strategies on a “frequent” basis. 
 
Parameters 
(mean +/- SD) 
Coping Strategies  
P- value             < 3  < or = 3 
Age (years) 53 +/- 6 53 +/- 9 0.91 
BMI( kg/m2) 35 +/- 6 36+/- 9 0.86 
ESS 17+/- 3 12+/- 5 < 0.0001 
ODI 38 +/- 24 41+/- 25 0.53 
Licence(years) 33+/- 8 31+/- 10 0.62 
DSS 11+/-7 4 +/- 5 < 0.0001 
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 Figure 6-2 showing the spearman’s correlation between ESS and coping strategies used 
“frequently” 
                    
 Figure 6-3 showing the spearman’s correlation between DSS and coping strategies used 
“frequently” 
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6.7.4- Relationship between Driving Sleepiness Score and Coping 
Strategies “frequently”  
OSAS patients who employed more than three coping strategies on a 
“frequent” basis were more likely to have had a DSS of more than 7 and this 
was statistically significant (P= < 0.0001, OR= 12). 10% of patients who had a 
DSS of less than 7 used any coping strategy “frequently”. A proportion of 
patients (17%) had a DSS of more than 7 and admitted to “frequent” use of 
more than three coping strategies, some had a DSS of more than 7 only with 
no “frequent” coping strategies (10%) and some neither to both (63%). This is 
shown in table 6-4.   
      Table 6-4 showing the relationship between frequently used coping strategies and DSS 
 
Coping Strategies DSS > 7 DSS < = 7 P= Value OR ( 95% CI) 
> 3 frequently 17% (17) 10% (9) 
< 0.0001 12  (4.1- 33) 
</= 3 frequently 10% (10)  63% (62) 
 
 
6.7.5- Relationship between Accident history and Coping Strategies 
“frequently”  
There was a significant difference in accidents (near misses, minor damage, 
major damage including garage work or insurance claims) or episodes of 
nodding at the wheel in the last year between OSAS patients who used > 3 
coping strategies “frequently” as compared to OSAS patients who used < 3 
coping strategies on a “frequent” basis. This is shown in table 6-5. 
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           Table 6-5 showing the relationship between accident history and coping strategies 
Accidents, Near miss or Nodding in the last one year P= Value Odds Ratio  
Coping Strategies Yes No 
 
 
0.005 
 
 
4.3 
 
 > 3 “ frequently” 
 
18 (78%) 5 (22%) 
 
</ = 3 “ frequently” 
 
34 (45%) 41 (55%) 
                                               
6.7.6- Relationship between MUoLDS outcome, performance based on 
SDLP-3 on and Coping Strategies “frequently” 
No controls and 20% (n= 20) of OSAS patients failed the MUoLDS 
irrespective of the use of any coping strategy “frequently” (P=value 0.69, 
OR=1.24). There was no difference in MUoLDS performance based on SDLP-
3 between controls and OSAS patients who used more than 3 coping 
strategies or less than three coping strategies (P= 0.06). There was a 
hierarchical pattern in the SDLP-3 between controls, OSAS patients who used 
less than three coping strategies “frequently” and those patients who used 
more than three coping strategies frequently (mean +/- SD (95% CI); 0.41 +/- 
0.12 (0.38-0.44); 0.46 +/- 0.20 (0.41-0.50); 0.50 +/- 0.29 (0.40-0.59) 
respectively. There was no difference between the three groups when 
corrected for multiple comparisons. This is shown in figure 6-4. 
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      Figure 6-4 showing the relationship between coping strategies and SDLP in epoch -3 
 
6.8- Discussion 
The principal outcome from this observational study was that behaviours 
adopted by untreated OSAS patients may be a useful additional way of 
identifying an individual who is potentially at risk of an accident, because of 
sleepiness while driving. I found feeling sleepy generally (ESS) or specifically 
while driving (DSS) correlate strongly with the adoption of various strategies 
to counter sleepiness. This confirms the hypothesis that using coping 
strategies may be a surrogate marker for sleepiness and might be a way of 
identifying patients who had a problem but did not admit to it directly. Of note 
10% of patients admitted to the use of at least one coping strategy 
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“frequently” but did not admit to significant sleepiness while driving 
(DSS</=7). I also found that OSAS patients using more than three strategies 
“frequently” are more likely to admit to a near miss or an accident in the 
previous year. 
 
Coping is a complex multidimensional process determined by environmental 
conditions, cognitive abilities, and personality dispositions [128]. A study 
comparing the driving habits of professional and non-professional drivers has 
shown that stopping for a short nap is effective in counteracting fatigue and 
benefits performance [129]. There is some limited data to suggest that 
stopping for a walk/exercise or stopping for a drink or particularly “washing the 
face” can have a positive effect, albeit for a short period in the general 
population [130-132]. It could be argued that measures which involve taking a 
break from driving are a legitimate and “appropriate” response to fatigue. 
However measures adopted while the patient continues to drive indicate that 
the individual is “fighting” sleepiness and might therefore be considered to be 
“inappropriate”. A post hoc analysis of our data comparing accident history 
and episodes of nodding in patients using coping strategies “appropriately” or 
“inappropriately” showed no difference, but the study may not have had 
sufficient numbers of subjects to address this issue definitively. My data 
suggests that strategies employed to counter fatigue are not effective but 
rather a marker of a patient who is driving with less reserves of alertness. 
Whether coping strategies are used “appropriately” or “inappropriately”, if it is 
“frequently”, it indicates that drivers are driving with increased sleepiness 
likely to impair safe driving. I suggest that the use of more than three coping 
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strategies “frequently” should be considered as a “red flag” with regard to 
future driving, but that any use of such strategies should raise concerns. 
 
6.9- Study Limitations 
Apart from the limitations described in Chapter-4 this study relied on patients’ 
reports of their driving. While it is possible that females use fatigue related 
counter measures in the same way as males this needs to be evaluated in 
future studies. I did not enquire when patients used the counter measures; for 
example stopping for a nap after 30 minutes is likely to be more significant 
than doing so after several hours. I do not know whether different counter 
measures were tried in the same journey. If yes it is further evidence that 
there is a problem; one does not seem to work so the individual tries 
something else. These are factors that the clinician will have to weigh in their 
assessment.  
 
6.10- Conclusion 
Patients with OSAS of sufficient severity to warrant a trial of CPAP use 
various coping strategies to deal with sleepiness while driving.  Use of more 
than three such measures “frequently” is associated with an increased risk of 
accidents and near misses and may be a complementary, and less 
threatening way to ask about sleepiness likely to impair safe driving. No 
control admitted to the use of more than three different coping strategies 
“frequently” and given the relationship with accidents and near misses, I 
suggest that this should be a “red flag” with regard to continued driving. Any 
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use of coping strategies should be a factor that is taken into account in 
assessing whether a patient has sleepiness likely to impair safe driving.  
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                                 Chapter-7 
 
Cognitive dysfunction and road traffic incidents 
in OSAS patients and controls 
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7.1- Abstract 
There has been a growing interest in the evaluation of cognitive deterioration 
and a wide range of cognitive deficits: general intellectual functioning, 
attention, memory, executive & motor functioning has been identified in 
patients with OSAS. Cognitive Failures Questionnaire (CFQ) is an 
assessment tool that is a measure of self-reported cognitive deficits in the 
completion of simple everyday tasks that a person should normally be 
capable of completing without error. I hypothesised those patients with OSAS 
exhibit worse cognitive dysfunction as compared to OSA patients and controls 
and higher CFQ score predicts accident risk. All completed a questionnaire 
that included CFQ, previous driving incidents in the last 1-year, ESS and 
DSS. They were asked how often they make various common mistakes on a 
5-point Likert scale, from 0 (never) to 4 (very often). CFQ was scored by 
adding up the rating for 25 questions, the highest possible total being 100, 
with a higher score indicating a higher incidence of cognitive failures. 
Prediction model using binary regression analysis identified accidents and or 
near miss and this was validated in a different cohort. 105 controls and 150 
patients were included in the exploratory; 68 controls and 198 patients in the 
validation. Untreated OSAS patients had a statistically significant higher CFQ 
score as compared to OSA patients and controls. The score remained 
statistically significant when different components of the CFQ were evaluated. 
Untreated OSAS patients with higher CFQ score reported increased driving 
incidents in the last one-year. The model was subsequently validated using 
ROC analysis. Sleepiness rather than severity of sleep disordered breathing 
predicts cognitive failure. Higher CFQ score is associated with accident risk. 
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The CFQ is easy to complete, may identify a different aspect of accident risk 
and therefore be useful in assessing fitness to drive in OSAS patients. 
 
7.2- Introduction 
OSAS is a common disorder with far reaching health implications. 
Deterioration in some cognitive domains is considered part of the aging 
process [133] but untreated OSAS results in cognitive dysfunction [134]. 
There is no consensus regarding the mechanisms by which OSAS affect 
cognition but it is thought to be multifactorial. Studies have shown deficits in 
various domains such as executive functions [135], memory [136], alertness 
[137] and attention [138]. Cognitive deficits in OSAS patients are qualitatively 
similar to those of elderly individuals, especially in tasks sensitive to frontal 
lobe dysfunction [139]. Cognitive dysfunction was independently related to 
both OSA severity and increasing age, but the coexistence of both factors did 
not result in increased cognitive deficit [140-141]. Impairment in attention 
plays a pivotal role in all aspects of cognitive deficits and thereby contributes 
to the poor performance of OSAS patients when compared to that of healthy 
individuals [138,142]. Brain activation is increased in OSA patients with 
preserved cognitive function as compared with the activation that occurs in 
healthy controls performing the same task. The association between 
preserved cognitive function, and greater activation in OSA patients suggests 
that increased cerebral recruitment is required to maintain cognitive 
performance [143]. The hippocampus is a region known to be closely 
associated with the neural processing of memory [144] and the morphology is 
altered in patients with OSAS [145-146]. 
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Driving a vehicle is a skill that involves complex integrated higher cortical 
function, alertness, concentration and hand-to-eye coordination. While errors 
of judgement cognitive failures occur frequently and many do not produce any 
serious consequences, some will results in accidents. Evidence suggests that 
there is a link between cognitive failures and road traffic accidents (RTA), 
distractibility, poor selective attention and mental error [147-149]. Annex III of 
the European Union (EU) Directive on Driving Licences was revised in 2014 
on the recommendations from a working group established by the Transport 
and Mobility Directorate of the European Commission in 2012 [51]. The UK 
Driver and Vehicle Licensing Agency (DVLA) changed their advice regarding 
who should not drive and who needs to notify them [50]. More over the current 
guidance [50] enquires about assessment of poor concentration especially in 
the absence of sleepiness.  
 
The EU Directive states that OSAS patients needing treatment, in the opinion 
of a physician and not receiving it should not receive an unconditional licence. 
A driver with moderate or severe OSAS may be permitted to drive based on 
demonstration of compliance with treatment. Patients with mild OSAS (AHI < 
15 events / hour) can drive if they do not have invalidating excessive 
sleepiness (ESS < 15), deny accidents, are not taking more than two drugs 
for hypertension, and have a BMI < 35 kg/m2. The UK DVLA regulations are 
also different for patients with mild compared to moderate and severe OSAS. 
Patients with mild OSAS and excessive sleepiness must not drive but do not 
need to inform the DVLA. Patients with moderate or severe sleep apnoea with 
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excessive sleepiness must not drive and must notify the DVLA; subsequent 
licensing will require control of the condition, an improvement in sleepiness 
and treatment adherence. The cardinal symptom of OSAS is excessive 
sleepiness and can have an adverse effect on driving [67]. If the patient is not 
sleepy and has moderate or severe OSAS they must not drive but do not 
need the DVLA. Driving may resume once associated symptoms, such as 
poor concentration, have been brought under control. These standards are 
higher for bus and lorry drivers. 
In this study I have evaluated whether the severity of SDB and / or poor 
decision making function impacts upon the likelihood of RTA.   
 
7.3- Study Outcomes 
7.3.3- Primary outcome 
To explore the relationship between CFQ score versus general sleepiness, 
severity of sleep disordered breathing and predicting accidents. 
7.3.4- Secondary outcome 
Comparing driving incidents between severity of SDB, general sleepiness and 
specifically whilst driving. 
  
7.4- Methods 
This is described in Chapter-4. Females were included in this study due to 
absence of MUoLDS test. Patients with SDB and an ESS of less than 10, 
irrespective of other symptoms were classified as OSA and patients with SDB 
and an ESS of more than 10 were classified as OSAS. Subjects with no 
symptoms of SDB and with an ESS of < 10 were recruited as controls. 
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Participants in both the groups were provided with a patient information leaflet 
and written consent was obtained. Ethics approval for this study was obtained 
from the NHS Research Ethics Committee (09/H1311/58). 
 
7.5- Questionnaire 
   7.5.1- Driving Questionnaire (DQ) 
This is described in Chapter-4.  
 
    7.5.2- Cognitive Failures Questionnaire (CFQ) 
To assess decision making function I used the CFQ [150]. This is a cognitive 
assessment tool which measures self-reported deficits in the completion of 
simple everyday tasks that a person should normally be capable of 
completing without error. It includes failures in attention, memory, perception 
and motor functions [24]. Allahyari et al [151] reported that CFQ could be 
used to identify drivers susceptible to driving errors. Patients and controls 
completed the CFQ, which enquired how often they make various common 
errors on a 5-point Likert scale, from 0 (never), 1 (very rarely), 2 
(occasionally), 3 (quite often) and 4 (very often). CFQ was scored by adding 
up the ratings for twenty-five questions, the highest possible total being one 
hundred, with a higher score indicating a higher incidence of cognitive 
failures. Allahyari et al [151] refined this further by performing a principal 
component analysis with varimax rotation to determine the factor structure of 
each domain; this gave five domains (“motor function”, “memory”, “lack of 
concentration”, “social interaction” and “names”). The DQ and the CFQ are 
described in detail in appendix (III and VI) respectively.  
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7.6- Study design and statistical analysis 
The study was divided into exploratory and validation phase. Statistical 
analysis was carried out using Graph Pad Prism 6 software (San Diego, 
California, USA) and SPSS statistics (Version 24; IBM, New York, USA). The 
level of significance was set at P= <0.05. In the exploratory phase we 
explored the total CFQ score and the five domains between controls, OSA, 
OSAS patients and controls. One way ANOVA and multiple comparison test 
(Bonferroni’s) was used to evaluate for demographic differences, differences 
in the total and the five domains of the CFQ between controls, OSA and 
OSAS patients. Spearman’s correlation was used to evaluate the relationship 
between ESS, DSS and ODI. Binary logistic regression analysis was used to 
test the hypothesis that an “accident” could be predicted from the either the 
total CFQ score or from any or all of the domains and thereby explore the 
possibility of developing a predictive model. Receiver operating characteristic 
(ROC) curve analysis was performed to calculate the discriminative power of 
the models and identify optimal cut-offs for probability score. The sensitivity, 
specificity and predictive powers of the models were calculated using the cut-
off values. The curve generated for each model was compared using the two 
proportion Z-tests in SPSS. 
 
7.7- Results 
 
   7.7.1- Baseline demographics 
 
The baseline characteristics in both the exploratory and the validation cohort 
are shown in table 7-1.  
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173 controls and 348 untreated OSAS patients were recruited to the study. In 
both the cohorts controls and patients were matched for age and driving 
experience. Patients as compared to controls had a worse ESS, BMI and this 
was statistically significant.   
  Table 7-1 Demographics in exploratory and validation cohort: controls and OSAS patients 
 
                                                          Controls 
Variables Exploratory study  
         (n=105) 
Validation study 
(n=68) 
P- Value CI of difference 
Age (Years) 55 + 14 56 + 14 0.68 -3.5 to 5.4 
ESS 4 + 3 3 + 2       0.12 -1.4 to 0.17 
BMI ( kg/m2) 28 + 6 28 + 4       0.37 -2.3 to 0.88 
   DL (years) 32 + 16 34 + 15 0.56 -3.4 to 6.3 
                                                       OSAS patients 
     Variables Exploratory study  
          (n=150) 
Validation study 
(n=198) 
P- Value CI of difference 
Age (Years) 53 + 12 53 + 11 0.45 -1.4 to 3.2 
ESS 14 + 5 13 + 6       0.09 -2.2 to 0.03 
BMI (kg/m2) 36 + 8 35 + 7 0.12 -2.7 to 0.31 
   DL (Years) 31 + 12 32 + 11 0.87 -2.2 to 2.6 
ODI 40 + 26 34 + 24 0.02 -11.30 to -0.73 
 
Data is presented as mean +/- SD, ESS: Epworth Sleepiness Score, BMI: Body Mass Index 
(kg/m2), DL: Driving Licence (years), ODI: Oxygen Desaturation Index, CI: Confidence 
interval 
 
7.7.2- Primary Outcome 
7.7.2.1- Exploratory study 
A- CFQ score between controls, OSA (ESS </=10) and OSAS (ESS > 10) 
patients 
There was a significant difference in the total CFQ score and in all the five 
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domains between controls, OSA and OSAS patients. On multiple comparison 
tests, there was no difference between controls and OSA patients but a 
significant difference between controls v/s OSAS patients and OSA v/s OSAS 
patients respectively as shown in table 7-2.  
 
B- CFQ score and severity of SDB 
Except for “names”, there was a statistically significant difference between the 
total CFQ score, “memory”, “lack of concentration”; “motor function” and 
“social interaction” between controls and patients with mild, moderate and 
severe sleep disordered breathing. However on multiple comparison testing 
(Bonferroni’s) there was no significant difference between the severities 
except between mild versus severe OSA. This was due to a smaller number 
of patients in the mild OSA subgroup and the mild OSA group being more 
sleepy compared to severe OSAS [ESS (mean/SD), 16 +/- 3 versus 13 +/- 5, 
P = 0.01, 95% CI= -4.7 to -0.58]. This is shown in table 7-3.  
 
C- Correlation of total CFQ score with ESS, DSS, ODI and age 
 
There was a good correlation between total CFQ score and ESS (r2 = 0.45, P 
= < 0.0001) and DSS (r2 = 0.39, P = < 0.0001) but a weak correlation with 
ODI (r2 = - 0.18, P = 0.02) and age (r2 = - 0.21, P = 0.007). 
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                                  Table 7-2, exploratory study; CFQ score between controls, OSA (ESS </=10) and OSAS (ESS>10) patients 
 
Parameter 
Mean (SD) 
Controls 
(n = 105 ) 
 
OSA 
(n = 38 ) 
 
OSAS 
(n =112 ) 
 
One-way ANOVA 
P-Value 
Bonferroni’s multiple testing correction: is p<0.05? 
Control v/s OSA Control v/s OSAS OSA v/s OSAS 
Total CFQ score 28 (11) 26 (15) 40 (20) < 0.0001 No Yes Yes 
Memory 8 (4) 8 (5) 13 (6) < 0.0001 No Yes Yes 
Lack of concentration 7 (4) 7 (5) 11 (6) < 0.0001 No Yes Yes 
Motor function 4 (2) 4 (3) 7 (4) < 0.0001 No Yes Yes 
Social interaction 5 (2) 5 (3) 7 (4) < 0.0001 No Yes Yes 
Names  3 (2) 2 (2) 3 (2) 0.02 No No Yes 
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                          Table7-3, exploratory study; comparison of CFQ score between controls and OSA patients, grouped by severity of SDB 
                    Parameter - Mean (SD)      Controls (n = 105 ) Mild (n = 26 ) 
 
Moderate (n = 40 ) 
 
Severe (n= 84) One-way ANOVA (P-Value) 
Total CFQ score 28 (14) 45 (24) 40 (18) 32 (19) < 0.0001 
Memory 8 (4) 14 (7) 13 (6)                 10 (6) < 0.0001 
Lack of concentration 7 (4) 12 (7) 10 (5) 9 (6) < 0.0001 
Motor function 4 (2) 8 (5) 7 (3) 5 (4) < 0.0001 
Social interaction 5 (2) 8 (4) 7 (4) 6 (3)    0.0001 
Names  3 (1) 3 (2) 3 (2) 3 (2) 0.15 
Bonferroni’s multiple testing correction: is p<0.05? 
Parameter 
Mean (SD) 
Control v/s Mild Control v/s Moderate Controls v/s Severe Mild v/s Moderate Mild v/s Severe Moderate v/s Severe 
Total CFQ score Yes Yes No No Yes No 
Memory Yes Yes No No Yes No 
Lack of concentration Yes Yes No No Yes No 
Motor function Yes Yes No No Yes Yes 
Social interaction Yes No No No Yes No 
Names No No No No No No 
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D- Regression analysis and ROC curve 
 
Binary regression analysis (step wise forward conditional) was done to 
develop a predictive model for accidents based on CFQ and derived from the 
individual domain scores. “Memory” (P= 0.01), “lack of concentration” (P= 
.001), “motor” (< 0.0001), “social interaction” (P= 0.05) and “names” (P= 0.02) 
were significant but the domain of “motor function” had the highest predictive 
power [PPV= 56.76%, 95% CI = 42.78% to 69.74% and NPV= 64.60%, 95% 
CI= 59.76% to 69.16%]. The area under the curve (AUC) was 0.67 (95% CI, 
0.58 to 0.74). The ROC curve is shown in figure 7-1.  
         
                           Figure 7-1 showing the ROC in the predictive model  
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7.2.2.2- Validation study 
The results in the total CFQ score and all the five domains were similar to the 
exploratory study. There was a good correlation with total CFQ score v/s ESS 
(r2 = 0.40, P = < 0.0001) and DSS (r2 = 0.41, P = < 0.0001) but a weak 
correlation with age (r2 = - 0.23, P = 0.0008) and no correlation with ODI (r2 = 
-0.06, P = 0.39) respectively. 6 patients had missing data for accident history. 
The total CFQ including all the domain scores was significantly higher in 
patients who reported either an accident and/or near miss in the last year. I 
could apply the exploratory model in 192 patients in the validation cohort. 
AUC was 0.65, similar to the exploratory model (AUC= 0.67), P= 0.74. The 
results are shown in Tables 7-4 and 7-5 respectively. 
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                                                         Table 7-4, validation study; CFQ score between controls, OSA and OSAS patients 
 
 
Parameter 
Mean (SD) 
Controls 
(n = 68 ) 
 
OSA 
(n = 68 ) 
 
OSAS 
(n =130 ) 
 
One-way ANOVA 
P-Value 
Bonferroni’s multiple testing correction: is p<0.05? 
Control v/s OSA Control v/s OSAS OSA v/s OSAS 
Total CFQ score 28 (14) 28 (17) 43 (18) < 0.0001 No Yes Yes 
Memory 9 (5) 9 (5) 13 (6) < 0.0001 No Yes Yes 
Lack of concentration 7 (4) 8 (5) 12 (5) < 0.0001 No Yes Yes 
Motor function 5 (3) 4 (3) 7 (4) < 0.0001 No Yes Yes 
Social interaction 5 (3) 5 (3) 8 (3) < 0.0001 No Yes Yes 
Names 2 (1) 3 (2) 4 (2) <0.0001 No No Yes 
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                                         Table 7-5, validation study; CFQ score between controls and OSA severity 
                          
Bonferroni’s multiple testing correction: is p<0.05? 
                     Parameter- Mean (SD) Control v/s Mild Control v/s Moderate Controls v/s Severe Mild v/s Moderate Mild v/s Severe Moderate v/s Severe 
Total CFQ score Yes Yes Yes No No No 
Memory Yes No Yes No No No 
Lack of concentration Yes Yes Yes No No No 
Motor function No No No No No No 
Social interaction Yes Yes Yes No No No 
Names Yes Yes Yes No No No 
Parameter - Mean (SD) Controls (n = 68) 
 
Mild (n =44) 
 
Moderate (n =67) 
 
Severe (n= 87) 
One-way ANOVA  
(P-Value) 
Total CFQ score 28 (14) 41 (20) 37 (20) 37 (18) 0.0005 
Memory 9 (5) 12 (7) 11 (6) 11 (5) 0.003 
Lack of concentration 7 (4) 12 (5) 10 (6) 10 (6) 0.0001 
Motor function 5 (3) 6 (5) 6 (4) 6 (4) 0.13 
Social interaction 5 (3) 7 (4) 7 (4) 7 (4) 0.008 
Names 2 (1) 4 (2) 4 (2) 4 (2) < 0.0001 
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7.7.3- Secondary outcome 
    7.7.3.1- Comparing driving incidents between severity of SDB, general 
                  sleepiness and specifically whilst driving 
As compared to controls, patients were more likely to report either a near miss 
(25% v/s 7%, P= < 0.0001, OR= 3.9), accidents (8% v/s 2%, P= 0.01, OR= 
3.5). This is similar to other studies that are listed in table1-2, Chapter-1. The 
incidence of driving incidents was significantly higher in patients who reported 
either a higher degree of sleepiness in general (ESS) or specifically whilst 
driving (DSS). There was no difference in the severity of sleep disorder 
breathing as shown in table 7-6.  
Table 7-6, showing the driving incidents between severity of SDB, general sleepiness and 
specifically whilst driving 
 
 
 
Parameters 
Accidents and or near miss  
 
P- value 
  
 
     Yes 
 
No 
 
OR 
 
95% CI 
Mild SDB (n=33) 36% (12) 64% (21) 
 
0.81 
 
    1.09 
 
0.51- 2.3 
Moderate/ Severe SDB (n =315) 34% (108) 66% (207)  
ESS < / = 10 (n =105) 24% (25) 76% (80) 
 
0.005 
 
      2 
 
1.2-3.4 
ESS > 10 (n = 243) 39% (95) 61% (148)  
DSS </ = 7 (n = 228) 29% (67) 91% (161)  
0.009 
 
1.83 
 
1.1-2.9 DSS > 7 (n = 120) 43% (52) 57% (68) 
 
  7.7.3.2- Driving incidents versus CFQ score 
The total CFQ including all the domain score was significantly higher in 
patients who reported either an accident history and/or near miss as shown in 
table 7-7. 
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                      Table 7-7, showing the CFQ v/s accident history and or near miss 
 
7.8- Discussion 
 
In this observational study I have shown that untreated OSAS patients, but 
not patients with OSA, are more likely to have had a near miss or an RTA in 
the last one year compared to controls. A higher CFQ score is associated with 
either a near miss and or an accident in the last one year; the domain of 
“motor function” being the strongest predictor. In both the exploratory and the 
validation cohorts I have shown that rather than the severity of sleep 
disordered breathing it is sleepiness that increases both cognitive dysfunction 
and accident risk. The presence of sleepiness (ESS > 10) predicts higher 
CFQ score and there was no difference either in the total CFQ score or any of 
the subscale scores between patients who were not sleepy (ESS </=10) and 
controls. Furthermore there was a good correlation with ESS, DSS and a 
weak correlation with severity of sleep disordered breathing.  
 
Both the DVLA interpretation and the EU directive put emphasis on the 
severity of SDB based on AHI, in determining how patients with OSA/OSAS 
should be advised about driving. 34% of our patients, with sleep disordered 
Parameter- Mean (SD) 
Accidents and or near miss 
P= Value Yes (n=61) 
(41%) 
No (n=89) 
(59%) 
Total CFQ score  43 (21) 35 (18) 0.001 
Memory 13 (7) 10 (6) 0.01 
Lack of concentration 12 (6) 8 (5) 0.0005 
Motor function 7 (4) 5 (4) 0.0002 
Social interaction 7 (4) 6 (3) 0.004 
Names 3 (2) 2 (2) 0.01 
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breathing and symptoms of sufficient severity to warrant a trial of CPAP 
reported an accident or near miss in the last year compared to 14% of 
controls. Data presented here suggest that the severity of the sleep disorder 
breathing, by itself, is not relevant as there was no difference in the 
percentage reporting accidents and / or near misses in those with mild 
compared to those with moderate or severe SDB. Sleepiness, both in general 
(ESS) and specifically while driving (DSS) appears to be more relevant but 
even so 24% of patients with an ESS of less than 10 and 29% with a DSS 
less than 7 reported an accident or near miss in the last year. These figures 
could be considered to be unacceptably high, being approximately twice the 
rate seen in controls, raising the question of whether driving should be 
advised against in any patient with OSAS of sufficient severity to warrant a 
trial of CPAP. This would be in keeping with the EU Directive regarding the 
importance of treatment deemed necessary by a physician. It does however 
have the danger of driving the problem underground, with patients not seeking 
medical advice or not trying CPAP for fear that they might lose their licence.  
 
The DVLA guidance suggests that in the absence of significant sleepiness 
other factors, only concentration is specifically mentioned, should be taken 
into account when advising patients about driving. My data suggest that 
cognitive function and sleepiness are closely linked and that in the absence of 
sleepiness patients are unlikely to have significant problems with cognitive 
function. A number of studies have shown structural brain damage in patients 
with OSAS [145-146] but it appears that most of the cognitive dysfunction is 
due to sleepiness and therefore reversible with treatment. This requires 
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further research. One of the strengths of this study was that the 
questionnaires were anonymised, making it more likely that patients would tell 
the truth.  The rate of accidents and near misses in our study was similar to 
other that reported in other studies (table 1-2, Chapter 1). However the 
previous studies did not take near misses into account. While intuitively 
reasonable that sleepiness likely to be likely to impair safe driving is more 
important than sleepiness in general this is not supported by my data. The 
accident / near miss rate in patients with an ESS greater than 10 was very 
similar to that in patients with driver sleepiness score greater than 7.  
 
The fact that the cognitive failures questionnaire was predictive of accidents 
and also correlated with sleepiness suggests that it could be used as an 
alternative, or complementary, approach in assessing the at risk driver. 
Patients may realise that admitting to sleepiness, particularly while driving, 
increases the risk that they will be advised to surrender their licence whereas 
the cognitive failures questionnaire effectively provides similar information but 
in a less obvious, and therefore less threatening, manner. However the 
cognitive failures questionnaire still relies on patient self-report. Objective 
tests of sleepiness as predictors of driving risk are disappointing and the use 
of objective tests of cognitive function might be more effective and are worthy 
of further investigation. 
 
 7.9- Study limitations 
This study only recruited patients with OSAS of sufficient severity to warrant a 
trial of CPAP; this is the group in which a risk assessment needs to be made 
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about an individual’s continued driving. It would not be appropriate to say that 
someone did not have OSAS of sufficient severity to warrant treatment but 
severe enough that a patient should not drive. The results are consistent with 
the EU Directive recommendation that a clinician determining that treatment 
with CPAP necessary is a key factor in determining whether an individual is at 
increased risk of an accident. However this study needs to be extended to 
patients with milder OSAS, as they may still be at increased risk of an 
accident. Controls did not undergo any objective screening. However the 
questionnaire included questions about symptoms of snoring or OSA and 
controls were only included if they had a low probability for OSAS. I think it is 
very unlikely that we included any controls with significant OSAS and the 
results of the driving simulation and the questionnaire would support this. I 
used a questionnaire to assess cognitive function and this is subject to the 
same limitations as a questionnaire about driving behaviours. However it has 
the advantage that it can be performed easily in patients attending a sleep 
clinic as it does not involve the same level of supervision as for an objective 
test. In practical terms a complementary approach could be considered. If a 
patient admits to cognitive failures there is no need to follow this up with more 
time consuming objective testing which can be reserved for those who deny 
problems but in whom there is a high degree of concern. This approach 
requires further evaluation and in particular the identification of the most 
appropriate tests of cognitive function relevant to driving accident risk. 
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7.10- Conclusions 
This study suggests that the severity of SDB is not relevant to driving accident 
risk and that the arbitrary classification of severity should be removed from 
guidance about driving in patients with OSAS. Sleepiness and cognitive 
failures appear to be a much better predictor of accident risk. However I found 
that even patients with a normal ESS or no significant sleepiness during 
driving, compared to controls, still reported an excessive number of driving 
events. My study was in patients for whom a trial of CPAP had been 
recommended by a clinician. However while there is unlikely to be significant 
disagreement between clinicians as to the appropriateness of CPAP in 
patients with severe symptomatic OSAS it is likely that different clinicians will 
draw the line at a different point in those with mild symptoms. Driving is such 
an important part of most patients everyday life that once it is decided that 
CPAP is appropriate treatment should be implemented with the minimum of 
delay. Further studies are needed to establish accident risk in patients with 
OSAS but not of sufficient severity to warrant treatment.
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                                               Concluding statement 
OSAS is an escalating problem with little sign of abating for health care services and 
clinicians. Many patients with OSAS drive a vehicle both for pleasure and as part of 
their employment. A key component in the management of OSAS involves 
appropriate risk assessment about driving in order to prevent RTA that carries a 
significant socioeconomic burden to society. Current guidelines endorsed by various 
medical societies and from licencing authorities have led to some consternation 
among patients, sleep apnoea support groups and clinicians. The research work 
presented in this thesis has provided significant insights into the fitness to drive and 
accident risk assessment in OSAS patients.  
 
The BTS driving survey highlighted the variability in the advice given and the 
discordant views about residual drowsiness and adequate CPAP compliance. 
Following this study BTS issued a position statement regarding driving and OSAS. 
However a repeat survey in 2015, using exactly the same vignettes [152] 
disappointingly suggested that the statement had had little impact. The change in 
emphasis from excessively sleepy to sleepiness likely to impair safe driving was felt 
to be helpful by a small majority. There is a clear need for tools which are felt to be 
robust by clinicians and patients to aid the decision making about fitness to drive.  
 
Neither accidents nor sleepiness while driving are unique to patients with OSAS and 
deciding which patients should not drive, and then justifying the decision to them, is 
difficult. Clinicians are dependent upon what patients say and it is considered likely 
by most clinicians that some patients may underestimate symptoms or not be truthful 
when answering questions about driving if they think that their licence might be at 
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risk.  When discussing sleepiness at the wheel patients sometimes state “everyone 
struggles sometimes” or something similar. Previous attempts at devising an 
objective test lacked credibility as a legitimate test of driving ability. I have therefore 
attempted to establish what constitutes “normal” sleepiness while driving in controls 
and contrasted this with patients with significant OSAS. I have described one of the 
few studies which provides objective criteria to help inform the decision making 
process and as far as am aware the only one which establishes what is “normal” 
sleepiness at the wheel (that does not mean that any sleepiness at the wheel is 
acceptable but does provide a robust justification for restricting driving in certain 
patients with OSAS). If patients answer questions about driving truthfully clinicians 
have a justification for their decision to restrict driving, which is based upon evidence. 
I have also suggested which patients, who deny problems driving, should be tested 
upon an advanced PC based driving simulator and criteria, and justification, for which 
should then be advised not to drive. By integrating self- report measures of 
sleepiness, safety-critical driving incidents and performance based on a driving 
simulator task, a number of red and amber flags are suggested to indicate that an 
individual is potentially at higher risk of having an accident due to sleepiness at the 
wheel and a clinician can have confidence that their decision that the patient be 
advised not to drive is reasonable and can be justified.  
 
Advanced PC based driving simulators have a role in identifying the at risk driver, 
and a proportion of OSAS patients who fail the MUoLDS can be reliably identified 
based on by SDLP. The randomised trial has shown that this continuously measured 
variable is repeatable with no effect of a simple incentive. However a proportion of 
patients had a change in MUoLDS outcome. Patients with high BMI or high ESS or 
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the worse severe SDB who pass the test should be considered for retesting, perhaps 
with some sort of distraction task or a drive of longer duration.  
 
OSAS patients report frequent use of certain measures or coping strategies to 
combat fatigue and some admit to sleepiness both generally and specifically while 
driving. These counter measures may be surrogate markers of fatigue and 
sleepiness. Asking about such strategies in clinical practice may aid the clinician in 
identifying the at risk patients.  
 
Sleepiness rather than severity of sleep disordered breathing predicts cognitive 
failure. Higher CFQ score is associated with accident risk. The CFQ holds promise, 
is easy to complete, may identify a different aspect of accident risk and therefore be 
useful in assessing fitness to drive in OSAS patients. Safe driving is not only related 
to driving without errors, but intentional violations and risky behaviours are also 
important components [153]. Unsafe behaviours originate from failures of information 
processing and action execution and also from deliberate deviations from rules and 
procedures. Therefore a model of cognitive failures causing unsafe behaviour should 
also be considered [154]. Objective tests of sleepiness as predictors of driving risk 
are disappointing and the use of objective tests of cognitive function might be more 
effective and are worthy of further investigation. 
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                                                     Further research  
The simulator run on MUoLDS was on in automatic mode with basic driving controls. 
It lacked certain advanced features such as a comfortable car seat, motion sensors, 
vehicle gear changes, the ability to measure pupillary changes to choreographed 
events on the simulator and video recording of both controls and OSAS patients. As 
a first step a second generation MUoLDS is needed. 
 
I. Further studies are required to validate the driving questionnaire, DSS and the 
normal range.   
II. The normal range described was exclusively in males with significant OSAS 
and further studies in a wider OSA population and in females are needed. 
III. The performance on the MUoLDS was based on SDLP at epoch 3. Further in 
depth analysis of each epoch should be undertaken for a better understanding 
of performance on the simulator both in controls and in a wider OSA 
population. 
IV. There is a need for a trial to test the issue of repeatability and the effect of 
incentives in controls.  
V. Coping strategies need to be evaluated in females along with validating these 
strategies. 
VI. A future model to predict accident risk by combing DSS, safety- critical driving 
incidents, coping strategies, CFQ score, MUoLDS outcome and performance 
holds promise.  
VII. Finally, further simulator studies are needed exploring non-motorway 
scenarios. 
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I- PARTICIPANT INFORMATION LEAFLET 
 
                                             Title of the Study 
A- Driving simulator performance in obstructive sleep apnoea  
Establishing a normal range and determining factors which influence simulator 
performance & optimal length of study 
 
Introduction 
You are being invited to take part in a research study. Before you decide, it is 
important that you understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Please ask us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part 
or talk about it with family or friends before making your decision. Any information 
you give during this study will not become part of your medical records or be made 
available to the clinicians involved in your care and will not be used to make any 
decisions about your ability to drive . 
 
What is the purpose of the study? 
Many people suffer from a condition known as obstructive sleep apnoea (OSA). 
During sleep the muscles of the upper airway relax causing a degree of narrowing.  
This may lead to partial obstruction which causes vibration and the noise of snoring. If 
more severe narrowing occurs the airway may be completely obstructed.  If this occurs 
the individual makes increasing efforts to breathe, but these are ineffective because the 
airway is simply sucked more tightly shut.  (It is analogous to trying to suck through a 
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straw that has lost its rigidity.)  After several efforts there is an arousal and the tone is 
immediately restored to the upper airway. A large breath, and usually snore, ensues 
and the individual immediately returns to sleep.  These arousals may last no more than 
a few seconds and the individual concerned is usually completely unaware that they 
are occurring. Occasionally they may awake with a sensation of suffocation or choking.  
If these episodes occur regularly sleep is disturbed and in particular the individual is 
prevented from entering the deeper stages of restorative sleep and suffers from sleep 
fragmentation.  As a consequence affected individuals are always tired and tend to fall 
asleep during the day. This may affect their ability to drive safely. 
 
In the research setting driving simulators (simulated driving using a computer) have 
been used to investigate some aspects of driving performance but it is not known 
whether these simulators are helpful in identifying those individuals who may have a 
problem maintaining concentration and vigilance while driving and those who have 
no such problems.   We are conducting this research to address this issue. 
 
Why have I been chosen? 
We wish to study patients with sleep apnoea & compare them with people who do 
not have sleep apnoea. You have been chosen because you fall into one of these 
categories. 
 
Do I have to take part?  
Participation is entirely voluntary. If you decide to take part, you will be given this 
information sheet to keep and asked to sign a consent form. If you decide to take 
part you are still free to withdraw at anytime and without giving a reason. 
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If you choose not to join this study or subsequently decide you no longer wish to take 
part , the hospital care you may receive in the future will not be affected. 
 
What will happen if I decide to take part? 
If you agree to take part in this research study, you first will be asked to sign the 
consent form attached at the back of this information leaflet. 
 
You need to be with us for about 2 hours. You will be asked to complete a 
questionnaire about your driving habits and various other questions about your 
health and everyday life.. You will then be asked to “drive” on a computer based 
driving simulator. The computer will have a large screen, steering wheel, foot pedals, 
a gear shift and realistic graphics. You will need to react to images on the computer 
screen just as if you were driving normally. . After a practice run of approximately 20 
minutes you will be asked to perform the test, which involves “driving” on a motorway 
for approximately 50 minutes.  You will be asked not to drink any caffeinated drinks 
(tea, coffee, hot chocolate, etc.) for at least 2 hours before the tests and until the test 
is completed. The session will be organized on a mutually convenient day.  
 
What are the possible disadvantages and risks of taking part? 
There are no risks involved.  
 
What are the possible benefits of taking part? 
Your participation in the study is unlikely to be of direct benefit to you. It is possible 
that performance on the simulator may give you some insights into your own driving 
performance. It should be stressed that the results from this study will not be used in 
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any way to advise you on whether you are safe to drive or not and the information 
derived from the study will not become part of your medical records or be made 
available to the clinicians responsible for your care.  
 
What if something goes wrong? 
If you are harmed by taking part in this research project, which is most unlikely, there 
are no special compensation arrangements. If you are harmed due to someone’s 
negligence, then you may have grounds for legal action. Regardless of this if you 
would like to complain about any aspect of the way you have been approached or 
treated during the course of this study the normal National Health Service compliant 
mechanism is available to you. 
 
Will my taking part be kept confidential? 
All information collected about you during the course of the research will be kept 
confidential. Identifiers such as your name or address will not be used in any 
publications or reports. All electronic data will be password protected and stored in a 
secure location. Each patient will be given a unique identity number from which all 
their results will be associated. Neither the researchers, nor the doctors involved in 
your care, will be able to identify an individual  from these results.  
 
 
What will happen to the results of the research study ? 
After the completion of our study, which we expect to last about 2 years we wish to 
publish them in an international medical journal & also would like to present them in 
conferences. Your identity will not be divulged in any report/publication unless you 
174 
 
have consented to release such information. If you would like to know about the 
outcomes of the research we would be happy to give it you. For that you need to 
contact us in the number given below. 
 
Further information 
 
This study is being conducted by Dr. Mark Elliott & his team at Leeds Teaching 
Hospitals NHS Trust. 
 
If you have any questions or require further information regarding the 
research, please contact: 
                                               Dr. Mark Elliott 
                                   Consultant Chest Physician 
                                 St James’s University Hospital 
                                               Leeds, LS9 7TF 
                              Email: mark.elliott@leedsth.nhs.uk 
                                             Tel. 0113 2065683 
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                                                   Title of the study  
B- Repeatability and effect of incentives on an office based advanced driving 
simulator to assess driving performance in Obstructive Sleep Apnoea 
Syndrome (OSAS) 
 
Introduction 
You are being invited to take part in a research study. Before you decide, it is 
important that you understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Please ask us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part 
or talk about it with family or friends before making your decision. Any information 
you give during this study will not be part of your notes and will not be used to inform 
your ability to drive in anyway. 
 
What is the purpose of the study? 
Many people suffer from a condition known as obstructive sleep apnoea (OSA). 
During sleep the muscles of the upper airway relax causing a degree of narrowing.  
This may lead to partial obstruction, which causes vibration and the noise of snoring. If 
more severe narrowing occurs the airway may be completely obstructed.  If this occurs 
the individual makes increasing efforts to breathe, but these are ineffective because the 
airway is simply sucked more tightly shut.  (It is analogous to trying to suck through a 
straw that has lost its rigidity.)  After several efforts there is an arousal and the tone is 
immediately restored to the upper airway. A large breath, and usually snore, ensues 
and the individual immediately returns to sleep.  These arousals may last no more than 
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a few seconds and the individual concerned is usually completely unaware that they 
are occurring. Occasionally they may awake with a sensation of suffocation or choking.  
If these episodes occur regularly sleep is disturbed and in particular the individual is 
prevented from entering the deeper stages of restorative sleep and suffers from sleep 
fragmentation.  As a consequence affected individuals are always tired and tend to fall 
asleep during the day. This may affect their ability to drive safely. Continuous Positive 
Pressure Ventilation or CPAP is the commonest treatment option for this condition.  
 
We are conducting this research in order to develop a test by which we can study 
driving behaviour in patients with sleep apnoea. In order to do that, we 
are trying to establish some of the qualities that should be the part of any reliable 
test. 
One of the most important issues to address is whether driving performance can be 
repeatable and the effect of the incentives on an office based advanced driving 
simulator. This study will try to address this issue. 
 
Why have I been chosen? 
We wish to study patients with sleep apnoea who drive. You have been chosen 
because you fall into this category. 
 
 Do I have to take part?  
Participation is entirely voluntary. If you decide to take part, you will be given this 
information sheet to keep and asked to sign a consent form. If you decide to take 
part you are still free to withdraw at anytime and without giving a reason. 
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If you choose not to join this study or subsequently decide you no longer wish to take 
part, the hospital care you may receive in the future will not be affected. 
 
What will happen if I decide to take part? 
If you agree to take part in this research study, you first will be asked to sign the 
consent form attached at the back of this patient information form. 
You need to be with us for about 2 hours. You will be asked to complete a 
questionnaire about your driving habits and your sleepiness. You will then undergo 
driving simulator tests. This will involve “driving” a computer based driving simulator. 
The computer will have a large screen, steering wheel, foot pedals, a gearshift and 
realistic graphics. You will need to react to images on the computer screen such as 
cars in front braking, overtaking, etc. After about 20 minutes of practice session you 
will be asked to perform the test, which involves “driving” on a motorway for 
approximately 50 minutes. You will be asked not to drink any caffeinated drinks (tea, 
coffee, hot chocolate, etc.) for at least 2 hours before the tests and until the test is 
completed. There will be two such sessions on 2 different days. 
 
What are the possible disadvantages and risks of taking part? 
There are no risks as such. Approximately 2% of people develop feelings of sickness 
with simulated driving. This is usually only mild, but if it occurs the test will be 
stopped. 
 
What are the possible benefits of taking part? 
Your participation in the study is unlikely to be of direct benefit to you. It is possible 
that performance on the simulator may give you some insights into your own driving 
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performance. It should be stressed that the results from this study will not be used in 
any way to advise you on whether you are safe to drive or not. 
 
WARNING This test has not been sufficiently well validated for the results from it to 
be used, at this stage, to make decisions about whether an individual is safe to drive 
or not. A good result on this test does not mean that you are safe to drive. Neither 
does poor performance on the driving simulator mean that you are not safe to drive. 
Decisions about whether you are safe to drive or not should still be made by you and 
your doctor (your doctor will not be informed about the results of this test). 
 
What if something goes wrong? 
            If taking part in this research project harms you there are no special compensation 
            arrangements. If you are harmed due to someone’s negligence, then you may have 
            grounds for legal action. Regardless of this if you would like to complain about any  
aspect of the way you have been approached or treated during the course of this 
study the normal National Health Service complaint mechanism is available to you. 
 
 
Will my taking part be kept confidential? 
All information collected about you during the course of the research will be kept 
confidential. Identifiers such as your name or address will not be used in any 
publications or reports. All electronic data will be password protected and stored in a 
secure location. Each patient will be given a unique identity number from which all 
his or her results will be associated. Neither the researchers, nor the doctors involved 
will be able to identify a patient from their results. Therefore we will not be able to 
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advise you on how well you have done. This is to protect those patients who may be 
reluctant to participate for fear they will be told they cannot drive afterwards.  
 
What will happen to the results of the research study? 
After the completion of our study, which we expect to last about 12 months we wish 
to publish them in an international medical journal & also would like to present them 
in conferences. Your identity will not be divulged in any report/publication unless you 
have consented to release such information. If you would like to know about the 
outcomes of the research we would be happy to give it you. For that you need to 
contact us in the number given below. 
 
Further information 
This study is being conducted by Dr.Mark Elliott & his team at Leeds Teaching 
Hospitals NHS Trust. 
 
If you have any questions or require further information regarding the 
research, please contact: 
 
                                               Dr.Mark Elliott 
                                     Consultant Chest Physician 
                                   St James’s University Hospital 
                                               Leeds, LS9 7TF 
                               Email: mark.elliott@leedsth.nhs.uk 
                                            Tel. 0113 2065683 
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II-                      CONSENT FORM 
 
Patient Label 
 
 
 
Patient Identification Number for this trial: 
 
 
                                                             Title of the Study  
 
A- Driving simulator performance in  obstructive sleep apnoea: Study A: Establishing a 
normal range 
 
                                               Name of Researcher: Dr.M.W.Elliott 
 
       Please initial box 
1. I confirm that I have read and understand the information sheet dated 08/02/09        
 (version 1.0) for the above study. I have had the opportunity to consider the  
      information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time,  
 without giving any reason, without my medical care or legal rights being affected.  
 
3.   I understand that relevant sections of any of my medical notes and data collected during   
the study, may be looked at by responsible individuals from  the NHS Trust, where it is  
relevant to my taking  part in this research.  I give permission for these individuals to have  
access to my records.  I also understand that after completion of the research the  
anonymized data might be published in an international journal.          
             
 
 
4.   I agree to take part in the above study.    
 
________________________ ________________ ____________________ 
Name of Patient   Date Signature 
 
 
 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
_________________________ ________________ ____________________ 
Researcher   Date  Signature 
 
 
When completed,  1 for patient;  1 for research file;  1 (original) to be kept in medical notes 
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Patient Label: 
 
 
Patient Identification Number for this trial: 
 
 
                                                           Title of the Study  
 
B- Repeatability and effect of incentives on an office based advanced driving simulator to 
assess driving performance in Obstructive Sleep Apnoea Syndrome (OSAS) 
 
                                              Name of Researcher: Dr.M.W.Elliott 
 
Please initial box 
 
1. I confirm that I have read and understand the information sheet dated 23.05.2012        
  
      (Version 2) for the above study. I have had the opportunity to consider the  
      information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time,  
  
      without giving any reason, without my medical care or legal rights being affected. 
 
3. I understand that relevant sections of any of my medical notes and data collected                  
during the study, may be looked at by responsible individuals from the NHS Trust,  
where it is relevant to my taking part in this research.  
 
4. I give permission for these individuals to have access to my records and also                                            
understand that after completion of the research the anonymized data                   
might be published in an international journal.                                                                        
                                                                                                                                                        
          
5.   I have read and understood the warning that how I perform on the simulator should                
      not be used as evidence of whether I am safe to drive or not.  
 
6.   I agree to take part in the above study.    
 
 
_______________              ________________                         ____________________ 
Name of Patient               Date                                             Signature 
 
 
_________________________    ______________                           ________________ 
Name of Person taking consent    Date                           Signature 
(if different from researcher) 
 
_________________________      _____________                          ___________________ 
Researcher                                      Date                                            Signature 
 
 
When completed, 1 for patient; 1 for research file; 1 (original) to be kept in medical not 
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III- Fatigue and Driving Questionnaire 
 
This questionnaire will help us to understand your driving habits, whether you are 
sleepy during the day and if so its effect on your everyday life. Your answers are 
confidential and will not be entered into your medical records & will not be 
used to judge your ability to drive in any way. Therefore please answer as 
honestly and accurately as possible. Please circle the most appropriate answer. 
Some questions may require more than one answer. 
 
Section A 
 
1.Do you snore?  
Never  
Occasionally  
Frequently  
Every night 
 
2. Has anyone ever commented that you stop breathing when you are asleep?  
Never  
Occasionally  
Frequently  
Every night 
 
3. Do you fall asleep during the day ? 
Never  
Only if I want to (eg choosing to take a nap)  
Only if bored or relaxing   
Sometimes even if occupied 
Often 
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Section B 
How likely are you to doze off or fall asleep in the following situations, in contrast to 
feeling just tired ? This refers to your usual way of life in recent times. Even if you 
have not done some of these things recently try to work out how they would have 
affected you. Use the following scale to choose the most appropriate number for 
each question. 
 
0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 
3 = high chance of dozing 
 
Situation         Chance of 
dozing 
 
Sitting & reading        _____________ 
 
Watching TV         _____________ 
 
Sitting, inactive in a public place (eg. Theatre or a meeting)  _____________ 
 
As a passenger in a car for an hour without a break   _____________ 
 
Lying down for a rest in the afternoon when circumstances permit _____________ 
 
Sitting & talking to someone      _____________ 
 
Sitting quietly after lunch without alcohol     _____________ 
 
In a car, while stopped for a few minutes in the traffic   _____________ 
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Section C 
 
1. How long have you had your driving licence? …….. yrs 
 
2. Does your job involve night shifts?  
 Yes   No 
If yes please give brief details of shift pattern 
 
3.  Are you a HGV/PSV driver?  
   Yes       No 
4.  How many miles would you normally drive in a year? 
More than 50,000 miles  
20,000 – 50,000 miles  
15,000 - 20,000 miles  
10,000 -15,000 miles  
5,000 -10,000 miles    
Less than 5,000 miles 
 
5.  Which best describes your pattern of driving ? ( Tick  the most appropriate answers) 
 
a) Only local journeys of less than 1 hour, never on motorways 
b) Mainly local journeys of less than one hour, occasional (less than once per month) 
longer journeys, never on motorways 
c) Mainly local journeys of less than one hour, occasional (less than once per month) 
longer journeys including motorway driving 
d) At least once per month drive for more than one hour, including motorway driving 
e) Regular journeys of at least one hour on all types of road 
 
 
 
185 
 
 
6. If you were to make a long journey for how long would you generally drive before 
stopping for a break? 
More than 4 hours  
3 - 4 hours  
2 - 3hours  
1- 2hours 
Less than 1 hour  
Never make long journeys 
 
7. How likely are you to doze off or feel sleepy while driving at each of the following 
times of day (if you do not drive at these times please try to imagine how you would 
feel then) ? (Circle the most appropriate answers) 
 
Early morning:  
Would never doze off / slight chance / moderate chance/ high chance/ don’t know  
Mid-morning:  
Would never doze off / slight chance / moderate chance/ high chance/ don’t know 
Noon time:  
Would never doze off / slight chance / moderate chance/ high chance/ don’t know     
Mid-afternoon:  
Would never doze off / slight chance / moderate chance/ high chance/ don’t know  
Evening:  
Would never doze off / slight chance / moderate chance/ high chance/don’t know 
Late at night :  
Would never doze off / slight chance / moderate chance/ high chance/don’t know  
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8. How likely are you to doze off or feel sleepy while driving the following types of 
journey? (Circle the most appropriate answers) 
Journeys less than 30 minutes 
Would never doze off / slight chance / moderate chance/ high chance/don’t know   
Journeys 30 minutes to one hour 
Would never doze off / slight chance / moderate chance/ high chance/don’t know  
Journeys one to two hours 
Would never doze off / slight chance / moderate chance/ high chance/don’t know   
Journeys more than two hours 
Would never doze off / slight chance / moderate chance/ high chance/don’t know   
Motorways 
Would never doze off / slight chance / moderate chance/ high chance/don’t know  
Urban roads 
Would never doze off / slight chance / moderate chance/ high chance/don’t know  
Country roads    
Would never doze off / slight chance / moderate chance/ high chance/don’t know  
  
9.Have you ever nodded off whilst driving? (Circle the most appropriate answers) 
During last 1 year  : Yes > 5 times  Yes 3-4 times Yes 1-2 times
 Never 
During last 3 years : Yes > 5 times  Yes 3-4 times Yes 1-2 times
 Never 
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11.Have you ever driven over the rumble strip on the motorway?  
(Circle the most appropriate answers) 
During last 1 year  :  Yes > 5 times  
Yes 3-4 times  
Yes 1-2 times  
Never         
Don’t drive on motorways 
 
During last 3 years :  Yes > 5 times  
Yes 3-4 times  
Yes 1-2 times  
Never         
Don’t drive on motorways 
 
12.  While you were driving, regardless of blame  
 1 year? 3 years? 
how many near misses have you had in the last   
how many accidents causing only minor damage have you had in the last   
how many accidents causing some damage requiring repair have you had in the last   
how many accidents involving major garage work or write off have you had in the last   
 
13. Regardless of blame have you reported any accidents to your insurer in the last  
1 year?  No / Yes (if yes number)…….. 
3 years? No / Yes (if yes number)…….. 
 
14. How much alcohol do you drink in a week? 
I don’t drink alcohol     
Less than 7 units  
7-14 units  
14-21 units   
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More than 21 units 
(1 Unit = equals half a pint of beer, a small glass of wine or a pub measure of spirits) 
 
Section : D 
1. How long since you last had a caffeinated drink (tea, coffee, etc)?  ……..hours 
2. What time did you go to sleep last night? ………….. 
3. What time this morning did you get up? ……………. 
4. How was the quality of sleep last night? 
Good  Average poor 
5. How would you rate your quality of sleep last night compared to your normal? 
Better  Same  Worse 
6. How alert do you feel now?  
Degree of Sleepiness 
Scale 
Rating 
Feeling active, vital, alert, or wide awake 1 
Functioning at high levels, but not at peak; able to concentrate 2 
Awake, but relaxed; responsive but not fully alert 3 
Somewhat foggy, let down 4 
Foggy; losing interest in remaining awake; slowed down 5 
Sleepy, woozy, fighting sleep; prefer to lie down 6 
No longer fighting sleep, sleep onset soon; having dream-like 
thoughts 
7 
Asleep X 
 
189 
 
 
 
 
 
 
IV- Protocol for the issue of repeatability and the effect of incentives on an 
office based advanced driving simulator ( MUoLDS) in OSAS patients 
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GENERAL INFORMATION 
PROJECT TITLE 
Repeatability and effect of incentives on an office based advanced driving simulator 
to assess driving performance in Obstructive Sleep Apnoea Syndrome (OSAS). 
 
PROJECT SUMMARY 
Patients with obstructive sleep apnoea syndrome (OSAS) are at increased risk of 
being involved in a road traffic accident (RTA), but not all patients with OSAS are 
unsafe drivers. The advice that a patient will receive about driving will depend upon 
their doctor’s attitude to risk and this is likely to be inconsistent between clinicians in 
the absence of objective criteria.  Currently advice about an individual’s fitness to 
drive is based upon the severity of the sleep disordered breathing, with or without 
some objective measure of daytime sleepiness and their account of their driving. 
Although there is a trend towards increased likelihood of accidents with more severe 
sleep disordered breathing there is no sufficient robust data on which to base 
decisions for an individual. There are conflicting data about the relationship between 
perceived sleepiness (ESS) and the likelihood of being involved in an accident.  
Driving requires alertness and also complex integrated higher cortical function; there 
is evidence that patients with OSA may have cerebellar and other neurological 
damage, which may impact on driving. Driving may therefore be impaired for reasons 
other than those just related to maintenance of alertness.   
 
A study done at the St.James University Hospital in collaboration with the Institute of 
Transport Studies, University of Leeds has shown that variables recorded during 
approximately fifty minutes of simulated motorway driving on the MiniSim can predict 
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with reasonable accuracy the patients with OSAS who will be involved in a crash in 
the simulated scenario.  Three groups of patients can be identified; those who crash 
when they really shouldn’t, those who do not crash at all and an intermediate group 
who crash in a situation in which even a reasonably alert driver might crash.  In our 
study, in which we deliberately tried to recruit patients most at risk of having 
problems while driving, many completed a 50 minute run on a realistic motorway 
without crashing, going off-road or veering out of lane. (Paper under review). The 
criteria that we used for “fail” are realistic and understandable to patients. This is very 
important if the test is to have credibility; an individual who fails on the simulator 
because they go off road multiple times might argue, quite reasonably, that this is not 
what happens when they drive a real car and therefore that the simulation is not 
valid. This is important if this test is going to be credible to patients and licensing 
authorities alike. While it might be reasonable to include an event such as our final 
“brake” event, as failure to avoid this is realistic evidence of sub optimal 
performance, at least during simulated driving, it has the disadvantage that it may 
limit the usefulness of the test for repeated use. A patient who is expecting 
something to happen may perform  differently the second time. Furthermore they 
may drive poorly at other times during the tests but, by chance, perform adequately 
at the event.  Variables that are recorded continuously throughout the test, and of 
which the patient is unaware, are preferable, for monitoring performance.  
 
In common with previous studies we found that poor lane control (SDLP) was related 
to a crash even when the lane control information was obtained from an epoch where 
no crash should have occurred (epochs 3, 5, 6 and 7). We confirm that it is a marker 
for poor driving performance and is a strong predictor of a crash in simulated 
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situations. Predictive power was increased by the inclusion of reaction time. Again 
previous studies have shown that untreated OSAS sufferers have worse reaction 
times than controls and patients with OSAS after CPAP therapy. Our study shows 
that there are differences even amongst the OSAS sufferers and this impact upon 
the likelihood of a crash; the reaction time at the veer event was different between all 
three groups. This is likely to be an underestimate as we had to exclude some 
patients from the analysis; some subjects (n=5) did not brake at all at the veer event 
and avoided a crash by veering out of lane, a legitimate manoeuvre, and others 
(n=4) did not brake at all and crashed.  Although this assessment requires an “event” 
the one programmed is a subtle extension of routine driving behavior and hence it is 
unlikely to be memorable. The fact that these abnormalities are detected early in the 
run means that it may be possible to use a shorter test, important in the clinical 
setting. 
If the MUoLDS is to be useful in the clinical setting it is important that the test should 
be repeatable; in other words it should give the same result when performed on 
different occasions. We have already established that there is no significant learning 
effect between the acclimatisation and definitive runs. A major concern about the use 
of any test, the result of which will be dependent upon the motivation of the subject, 
is that the individual may be able to "raise their game" if their driving licence is at 
stake. We now wish to investigate these issues further. 
 
AIM 
To study the repeatability and effect of incentives on an office based advanced 
driving simulator to assess driving performance in Obstructive Sleep Apnoea 
Syndrome (OSAS). 
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METHODS 
Patients attending the Sleep Clinic at St James's University Hospital will be 
asked to participate in the study. All subjects will be asked to perform a simulator run, 
after an initial acclimatisation, on two separate occasions. Subjects will be randomly 
allocated to one of two groups. Group A will be asked to perform a similar to run on 
two separate occasions. Group B will be asked to do the same thing but just prior to 
the final run will be told that if they can improve their performance by 10% they will 
be given a £20 gift voucher from the Trust fund. Subjects will not be told how this will 
be measured but it will be based upon the change in SDLP in epoch 3. 
 
ANALYSIS OF RESULTS 
 SDLP in epoch 3 and “veer” reaction time will be the co-primary 
outcome variables.  
 Classification of patients into "pass", "fail" and "indeterminate" will be 
secondary outcome variables.  
 Repeatability - SDLP in epoch 3 and veer reaction time in run 1 will be 
compared with run 2 in groups A using paired T tests, with the level of 
significance set at p <0.05 
 Effect of incentives - the difference in SDLP and veer reaction time in 
run two will be compared between groups A and B, using unpaired T tests, 
with the level of significance set at p <0.05 
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SAMPLE SIZE 
There are standard recommendations for sample size for looking at reproducibility 
and agreement taken from Martin Bland's work. We will recruit 50 subjects for the 
repeatability and 100 for the effect of incentive components of the study. 
 
DISSEMINATION OF RESULTS AND PUBLICATION POLICY 
The initial results will be presented as abstracts in various national and international 
meetings and conferences with a view to publish it as a paper in a peer reviewed 
journal. 
 
DURATION OF THE PROJECT 
Recruitment is expected to take 12 months. 
 
ETHICS 
Approved by Leeds Ethical Committee 
 
INFORMED CONSENT 
All participants will sign a consent form. One copy form will be filed in the case notes, 
one given to the patient and one retained by the researcher. 
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                                 V- Coping Strategies Questionnaire  
1- Have you ever done any of the following in the last 1 year in order to stay 
awake whilst driving? 
           (tick as appropriate) 
 Never Occasionally  Frequently 
Stopped for a nap    
Stopped for a walk/exercise    
Opened the window    
Turned up the radio/stereo    
Stopped to drink tea/coffee    
Stopped at service area to wash face in  
cold water 
   
Sing / talk to yourself    
Chew gum/ eat something    
Fidget / exercise    
Smoke    
Changed seat position    
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                                      VI- Cognitive Failure Questionnaire  
The following questions are about minor mistakes which everyone makes from time 
to time, but some of which happen more often than others. We want to know how 
often these things have happened to your in the past 6 months.  Please circle the 
appropriate number. 
 
  Very 
often 
Quite 
often 
 Occasionally 
 
Very  
rarely 
Never 
1. Do you read something and find you 
haven’t been thinking about it and 
must read it again? 
 
    4     3     2     1     0 
2. Do you find you forget why you went 
from one part of the house to the 
other? 
 
    4     3     2     1     0 
3. Do you fail to notice signposts on the 
road? 
 
    4     3     2     1     0 
4. Do you find you confuse right and left 
when giving directions? 
 
    4     3     2     1     0 
5.   Do you bump into people? 
 
    4     3     2     1     0 
6. Do you find you forget whether 
you’ve turned off a light or a fire or 
locked the door? 
7.  
    4     3     2     1     0 
 7.       
8. Do you say something and realize 
afterwards that it might be taken as 
insulting? 
 
    4     3     2     1     0 
9. Do you fail to hear people speaking 
to you when you are doing something 
else? 
 
    4     3     2     1     0 
10. Do you lose your temper and regret 
it? 
 
    4     3     2     1     0 
11. Do you leave important letters 
unanswered for days? 
 
    4     3     2     1     0 
12. Do you find you forget which way to 
turn on a road you  
know well but rarely use? 
 
    4     3     2     1     0 
13. Do you fail to see what you want in a 
supermarket (although it’s there)? 
    4     3     2     1     0 
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14. Do you find yourself suddenly 
wondering whether you’ve used a 
word correctly? 
 
    4     3     2     1     0 
15. Do you have trouble making up your 
mind? 
 
    4     3     2     1     0 
16. Do you find you forget appointments? 
 
    4     3     2     1     0 
17. Do you forget where you put 
something like a newspaper or a 
book? 
 
    4     3     2     1     0 
18. Do you find you accidentally throw 
away the thing you want and keep 
what you meant to throw away – as in 
the example of throwing away the 
matchbox and putting the used match 
in your pocket? 
 
    4     3     2     1     0 
19. Do you daydream when you ought to 
be listening to something? 
    4     3     2     1     0 
20. Do you find you forget people’s 
names? 
 
    4     3     2     1     0 
21. Do you start doing one thing at home 
and get distracted into doing 
something else (unintentionally)? 
 
    4     3     2     1     0 
22. Do you find you can’t quite remember 
something although it’s “on the tip of 
your tongue”? 
 
    4     3     2     1     0 
23. Do you find you forget what you 
came to the shops to buy? 
 
    4     3     2     1     0 
24. Do you drop things? 
 
    4     3     2     1     0 
25. Do you find you can’t think of 
anything to say? 
    4     3     2     1     0 
 
 
 
